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Abstract 
During mammalian erythropoiesis, hematopoietic stem cells develop into erythroblasts, which 
form blood islands with macrophages and further extrude the nucleus during terminal 
differentiation into erythrocytes. The production of erythrocytes dramatically increases in stress 
erythropoiesis, such as during fetal development or anemia. There is increasing knowledge about 
hormonal signaling regulating steady state and stress erythropoiesis and new insights into 
molecular pathways essential for erythroblast differentiation. However, the molecular pathways 
involved in erythroblast differentiation, especially under stress conditions are still largely 
unknown.  
It was shown previously that mice lacking p38α in embryonic tissues or specifically in 
hematopoietic cells show increased numbers of nucleated erythrocytes in the fetal liver and 
newborn peripheral blood. Moreover, phenylhydrazine (PHZ)-induced anemia increases the 
number of nucleated erythrocytes in the spleen and peripheral blood of mice with hematopoietic 
deletion of p38α. Additionally, erythroblasts lacking p38α almost completely fail to enucleate 
during in vitro differentiation, suggesting that the function of p38α in enucleation is cell-
autonomous. 
Here I will describe my attempts to identify substrates of p38α, which are essential for 
erythroblast enucleation. Furthermore, I will demonstrate that the function of p38α in 
enucleation of erythroblasts is cell-autonomous and that p38α is a key mediator of erythroid 
differentiation under stress conditions. The impaired enucleation phenotype is recapitulated in 
mice lacking p38α specifically in the erythroid lineage, but not in mice with macrophage-
specific deletion of p38α. Moreover, p38α-deficient erythroblasts show aberrant expression of 
genes related to erythroid differentiation, such as Gata1 and different hemoglobin isoforms. The 
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impaired enucleation phenotype of p38α-deficient erythroblasts is similar to that of erythroblasts 
lacking Rb. Importantly, negative regulators of Rb, such as p53, p21 and p27 were down-
regulated and the level of hyperphosphorylated Rb is increased in p38α-deficient erythroblasts. 
Gene expression profiling analysis also reveals that target genes of E2F-1, which is repressed by 
Rb, are up-regulated, such as Cyclin E, Cdk2 and Pcna. These data indicate that p38α is essential 
for enucleation of erythroblasts in a cell-autonomous manner and for the regulation of 
differentiation-related gene expression under stress erythropoiesis, likely through activating the 
Rb pathway.  
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Zusammenfassung 
Während der Erythropoiese von Säugetieren entwickeln sich hämatopoetische Stammzellen zu 
Erythroblasten, welche zusammen mit Makrophagen Blutinseln bilden und in der terminalen 
Differenzierung zu Erythrozyten schließlich den Nukleus ausstoßen. In der Stresserythropoiese, 
wie zum Beispiel während fötaler Entwicklung oder Anämie,  nimmt die Produktion von 
Erythrozyten dramatisch zu. Es gibt ein stetig wachsendes Wissen über hormonelle Regulierung 
von Basal- und Stresserythropoiese und neue Einblicke in molekulare Netzwerke, welche 
essentiell für die Erythroblastendifferenzierung sind. Die molekularen Netzwerke der 
Erythroblastendifferenzierung, besonders in Stresssituationen, sind jedoch noch immer 
größtenteils unbekannt.  
Zuvor wurde gezeigt, dass Mäuse denen p38α im embryonalen Gewebe oder in 
hämatopoetischen Zellen fehlt, eine erhöhte Anzahl an nuklerierten Erythrozyten in der fötalen 
Leber und im peripheren Blut von Neugeborenen aufweisen. Darüberhinaus wird die Anzahl von 
nukleierten Erythrozyten in der Milz und dem peripheren Blut von Mäusen mit spezifischer 
Deletion von p38α in hämatopoetischen Zellen durch Phenylhydrazin induzierte Anämie erhöht. 
Zusätzlich wurde gezeigt, dass p38α-defiziente Erythroblasten während der in vitro 
Differenzierung fast komplett versagen zu enukleieren. Dies legt nahe, dass die Funktion von 
p38α in der Enukleierung zellautonom ist. 
In der hier vorliegenden Arbeit beschreibe ich meine Versuche Substrate von p38α zu 
bestimmen, welche essentiell für die Enukleirung von Erythroblasten sind. Weiteres zeige ich, 
daß die Funktion von p38α in der Enukleierung von Erthroblasten zellautonom ist und daß p38α 
eine Schlüsselfunktion in der erythroiden Differenzierung in Stresssituationen hat. Der Phänotyp 
der gestörten Enukleierung wird in Mäusen, denen p38α speziell in der erythroiden Linie fehlt, 
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aber nicht in Mäusen mit spezifischer Deletion von p38α in Makrophagen rekapituliert. 
Zusätzlich haben p38α-defiziente Erythroblasten abweichende Expression von Genen, welche 
mit der erythroiden Differenzierung in Zusammenhang stehen, wie zum Beispiel Gata1 und 
diverse Hämoglobinisoformen. Der Phänotyp der gestörten Enukleierung ähnelt dem von Rb-
defizienten Erythroblasten. Wichtig ist, daß p38α-defiziente Erythroblasten ein reduziertes Maß 
an negativen Regulatoren von Rb, und zwar p53, p21 und p27, und ein erhöhtes Maß an 
hyperphosphorylierten Rb aufweisen. Ebenso hat eine Analyse des Genexpressionsprofils 
ergeben, dass Zielgene von E2F-1, welcher von Rb repremiert wird, hochreguliert sind; zum 
Beispiel Cyclin E, Cdk2 und Pcna. Diese Daten zeigen, daß die Rolle von p38α in der 
Enuklerierung von Erythroblasten während der Stresserythropoiese zellautonom ist und p38α 
essentiell ist für die Regulierung von differenzierungsbezogener Genexpression.  Darüberhinaus 
vermute ich, daß p38α seine Funktionen durch die Aktivierung des Rb Singalweges ausübt. 
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1. Introduction 
1.1. Mammalian erythropoiesis: from multipotent progenitors to 
mature erythrocytes 
 
1.1.1. Ontogeny and origins of erythropoiesis in mammals 
Erythropoiesis is the process in which multipotent stem cells develop into erythroblasts, which 
next form mature erythrocytes. During mammalian erythropoiesis erythroblasts extrude the 
nucleus during terminal differentiation into erythrocytes, which is characteristic for mammals 
and almost unique in the animal kingdom [2, 3]. In mammals erythrocytes circulate in 
cardiovascular system and are crucial for oxygen supply to the entire organism. A cardiovascular 
system including functional erythrocytes is essential for development, growth and survival of an 
organism from the beginning of embryonic post-implantation period throughout its whole 
lifespan [4]. Hence, the onset of erythropoiesis is required in early stages of embryonic 
development. Until today the ontogeny and developmental origins of erythropoiesis in mammals 
have been studied intensively and reviewed comprehensively (reviewed in refs. [1, 5]). 
During embryonic development the initial population of erythrocytes circulating in the capillary 
network consists of primitive erythrocytes. It is characteristic for primitive erythrocytes to 
mature intravascular and to retain the nucleus. Additionally, primitive erythrocytes accumulate 
fetal hemoglobin and have a relatively large size (Fig.1) [1]. Contradictory to a long hold 
opinion, it has been shown that primitive erythrocytes are capable to enucleate later in 
development [6]. Primitive erythrocytes derive from a transient population of primitive 
erythroid-colony forming cells (EryP-CFC). EryP-CFCs, which are located in the yolk sac and 
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are observable in the murine embryo at E7.25 earliest [7]. At E7.5 EryP-CFCs rapidly give rise 
to primitive erythroid cells in the mesoderm layer of the yolk sac. The arising primitive erythroid 
cells form pools, which are termed “blood islands” [1, 8]. Subsequently, the blood islands 
become enveloped by endothelial cells, which also form the initial vascular plexus of the yolk 
sac, due primitive erythrocytes mature intravascular [9]. The primitive erythrocytes start 
circulating and enter the embryo proper concurrently with the onset of cardiac function at E8.25 
[10]. Up to E12 only primitive erythrocytes circulate in the embryo. Therefore, the formation of 
primitive erythrocytes is essential for accurate oxygen supply and survival of the embryo at early 
stages of fetal development [11].  
 
 
 
With the beginning of E12 circulating primitive erythrocytes are successively replaced by fetal 
definitive erythrocytes released from the fetal liver. Fetal definitive erythrocytes are defined by a 
relative small size in comparison to primitive erythrocytes, by accumulation of adult hemoglobin 
and most prominently by the absence of a nucleus (Fig. 1) [1]. However, fetal definitive 
erythrocytes are twice as large and accumulate twice as much hemoglobin as adult definitive 
erythrocytes [6]. Noteworthy, definitive erythrocytes undergo enucleation and terminal 
Figure 1. Morphological differences 
of primitive and adult definitive 
erythroid cells in the mouse. 
Peripheral blood from E9.5 embryos 
and adult mice were mixed together, 
cytospun, and stained with Wright-
Giemsa. The primitive erythroid cells 
are nucleated and at the basophilic stage 
of maturation. On the other hand, 
definitive erythrocytes are enucleated 
and markedly smaller. (Figure was 
adapted from McGrath, 2008 (ref. [1])) 
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differentiation before entering the blood stream [1]. Progenitors of early fetal definitive 
erythropoiesis are yolk sac-derived burst forming unit erythroid (BFU-E) cells. BFU-Es emerge 
in the yolk sac at E8.25 and start circulation with the onset of cardiac function [12]. These yolk 
sac-derived BFU-Es populate the newly formed fetal liver at E10 and subsequently generate fetal 
definitive erythrocytes. At E12 the first mature fetal definitive erythrocytes start the circulation 
[7].  
After that, it is assumed that yolk sac-derived BFU-Es in the fetal liver are successively replaced 
by BFU-Es derived from long term hematopoietic stem cells (HSC). HSCs begin to populate the 
fetal liver at E11 and give rise to diverse progenitors of the hematopoietic system including 
BFU-Es. HSC-derived BFU-Es are responsible for continued fetal definitive erythropoiesis in the 
fetal liver till birth and for adult definitive erythropoiesis in the bone marrow as well. After birth 
definitive erythropoiesis in the fetal liver ceases rapidly and adult definitive erythropoiesis takes 
place in the bone marrow [1]. 
Because of the different populations of progenitors for primitive and definitive erythropoiesis, it 
is reasonable that these progenitors derive from various developmental origins. It is assumed that 
erythroid progenitors originate from two distinct lineages. The progenitors for primitive and 
early fetal definitive erythropoiesis, EryP-CFCs and BFU-E, arise in the yolk sac and are 
considered to share a common progenitor; the hemangioblast precursor. The hemangioblast 
precursors contain potential to give rise to hematopoietic and epithelial cells. Hemangioblast 
precursors undergo an early commitment to hematopoietic or vascular linage and therefore are 
not found in the yolk sac themselves. Importantly, it has been shown that hemangioblast 
precursors contain potential for primitive and definitive erythroid cells. Hence it is reasonable 
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that primitive erythroid and first definitive erythroid cells originate from hemangioblast 
precursors.  
As mentioned before, the progenitors of late fetal and adult definitive erythropoiesis derive from 
long term HSCs. In contrast to yolk sac-derived progenitors, HSCs originate from 
intraembryonic source. HSCs arise at the paraaortic splanchnopleura region at E8.5-10 [1]. 
Incidentally, the paraaortic splanchnopleura region is termed aorta-gonad mesonephros region 
later in development [13]. During development HSCs are distributed over the blood stream and 
populate the thymus at E10.5, the fetal liver at E11, the splenic rudiment at E12.5 and the bone 
marrow at E16 [5, 14]. HSCs give rise to erythroid progenitors in the fetal liver and bone marrow 
and thereby drive the late fetal and adult definitive erythropoiesis. 
Taken together the ontogeny of erythropoiesis in mammalian embryos can be simplified in a 
model of three succeeding waves as described by McGrath [1]. The first wave encompasses the 
primitive erythropoiesis, which consists of EryP-CFCs that give rise to primitive erythrocytes. 
The second wave encompasses the early definitive erythropoiesis, which is located in the fetal 
liver and consists of yolk sac-derived BFU-Es that give rise to fetal definitive erythrocytes. The 
third and final wave consists of HSC-derived BFU-Es, which are responsible for continued 
definitive erythropoiesis in the fetal liver up to birth and ultimately for adult definitive 
erythropoiesis in the bone marrow (Fig. 2) [1].  
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Figure 2. Three wave model of erythroid ontogeny in the mammalian embryo. The model is 
described in the text. (Figure was adapted from McGrath, 2008 (ref. [1])) 
 
1.1.2. Adult definitive erythropoiesis 
At normal physiological conditions 27 x 1012 erythrocytes circulate in blood stream of adult 
humans [15]. The total life span of an erythrocyte endures 120 days. Since life span of 
erythrocytes is restricted, the pool of erythrocytes has to be renewed constantly. The definitive 
erythropoiesis in adults has evolved as a steady state process in which the formation and 
degradation of erythrocyte balance each other [15]. For humans it has been calculated that a total 
number of 2 x 106 erythrocytes have to emerge per second [15]. 
At normal physiological conditions erythropoiesis takes place in the bone marrow and is 
maintained by continuous generation of erythroid progenitors derived from HSCs [16]. HSCs are 
capable to give rise to all types of blood cells, such as lymphocytes, granulocytes, neutrophils, 
monocytes, macrophages, osteoclasts, thrombocytes and also erythrocytes (Fig. 3A) [17]. 
According to this HSCs are multipotent stem cells, which have to undergo several steps of 
commitment and differentiation in order to generate mature progenies. 
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The first unipotential progenitors for the erythroid lineage are BFU-Es [18, 19]. The next stage, 
downstream of BFU-Es, consists of colony forming unit-erythroid (CFU-E) cells. BFU-Es and 
CFU-Es are defined by their colony-forming potential in vitro using semisolid medium 
containing EPO. Human BFU-Es are defined by the ability to give rise to an erythroid “burst” of 
approximately 1000 erythroid cells in vitro. In contrast, CFU-Es give rise to colonies consistent 
of up to 64 erythroid cells [19, 20].  
The following steps of erythroid differentiation downstream of CFU-Es consist of rapidly 
maturating erythroblasts. Those erythroblasts have limited potential of self renewal and pass 
defined stages of maturation. The most immature erythroblasts are proerythroblasts. These 
proerythroblasts differentiate into basophilic erythroblasts under continuous cell proliferation 
[21]. Next, basophilic erythroblasts progress to polychromatophilic erythroblasts while 
proliferation ceases [22]. Afterwards polychromatophilic erythroblasts differentiate into 
orthochromatophilic erythroblasts. Relevantly, during these stages of maturation erythroblasts 
undergo rapid morphological changes. Differentiating erythroblasts continuously decrease their 
size, accumulate hemoglobin, and undergo progressive nuclear condensation [23].  
During the terminal steps of erythroid differentiation orthochromatophilic erythroblasts extrude 
the nucleus and form reticulocytes. Besides, the extruded nucleus forms the transient pyrenocyte. 
Next, these reticulocytes degrade ribosomes and expel organelles. Finally, reticulocytes become 
biconcave discoid shaped in order to form mature erythrocytes, which enter the blood stream 
(Fig. 3B) [16].  
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Figure 3: HSCs undergo several stages of differentiation and commitment to from mature 
progenies. (A) Schematic overview of hematopoiesis and its diverse progenies. The erythroid 
lineage is bordered in red. (B) Depiction of maturation stages of the erythroid lineage; from 
proerythroblast to erythrocyte. (Figure 3A was adapted from Metclaf D., Blood lines, 2007; 
AlphaMed Press. Figure 3B was adapted from Xira X, available at 
http://en.wikipedia.org/wiki/File:Hematopoiesis_(human)_diagram.png, update 05/22/2007.)  
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Noteworthy, the number of erythroid progenitors is significantly higher as it is demanded for the 
production of erythrocytes required under normal physiological conditions. To avoid 
overproduction of erythrocytes during steady state erythropoiesis, surplus erythroid progenitors 
undergo apoptosis. However, the overproduction of erythroblasts serves as a reservoir to increase 
the production of erythrocytes immediately in situation of higher demands, such as severe blood 
loss. The activation of the erythroblasts reservoir is regulated by a process termed as stress 
erythropoiesis, which is described in more detailed in the following paragraph [23]. 
 
1.1.3. Stress erythropoiesis 
Under normal physiological conditions adult erythropoiesis is a steady state process in order to 
constantly renew the pool of erythrocytes. Beyond normal physiological conditions adult 
erythropoiesis acts as a highly dynamic process that responds to altered demands quickly. Severe 
blood loss, anemia of multiple etiologies and therapeutic procedures such as chemotherapy, 
generally result in tissue hypoxia. In response to tissue hypoxia, the production rate of 
erythrocytes is increased immediately by stress erythropoiesis. In contrast to steady state 
erythropoiesis, which is located in the bone marrow, stress erythropoiesis additionally takes 
place in the spleen. Stress erythropoiesis is stimulated by a 1000-fold increase in erythropoietin 
(Epo) levels, glucocorticoids, bone morphogenic proteins (BMP) and stem cell factors. These 
factors enhance the proliferation, reduce the doubling time and promote survival of erythroid 
progenitors [23]. Furthermore, erythroid differentiation is accelerated during stress 
erythropoiesis as well (Fig. 4) [24, 25]. 
The primarily function of Epo is to promote survival of erythroid progenitors during steady state 
as well as stress erythropoiesis by antiapoptotic effects [26]. The increased Epo level during 
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stress erythropoiesis results directly in an increased survival of erythroid progenitors. For 
instance, Epo antagonizes Fas-mediated apoptosis of erythroblasts by down-regulating 
expression of Fas and FasL, which subsequently results in reduced levels of Fas and FasL 
molecules on surface of proerythroblasts and basophilic erythroblasts [23]. In addition, Epo-
signaling activates STAT5, which subsequently up-regulates the antiapoptotic gene bcl-x [27]. 
Both, antagonizing Fas / FasL signaling and up-regulation of bcl-x enhance erythroblasts 
survival and contributes to increased erythrocyte production.  
Glucocorticoid-signaling during stress erythropoiesis promotes proliferation of early erythroid 
progenitors, which leads to increased production of erythrocytes as well. In vitro, glucocorticoids 
are capable to inhibit differentiation and promote self-renewal of CFU-Es [28]. Notably, 
overexpression of dominant negative glucocorticoid receptor mutant in mice abrogates the 
expansion of CFU-Es in response to acute anemia [29]. 
Additionally, during the recovery from acute anemia a distinct population of BFU-Es is found in 
the spleen, which is termed stress BFU-Es. In contrast to BFU-Es from steady state 
erythropoiesis, stress BFU-Es have reduced doubling time and only require the addition of Epo 
to form colonies in vitro. The BMP4/Smad5 signaling pathway was shown to be essential for the 
mobilization of stress BFU-Es in the spleen [24]. Noteworthy, erythrocytes produced during 
adult stress erythropoiesis, are increased in size and also contain fetal hemoglobin [30].  
During fetal development the rapid growth of the embryo demands a likewise rapid expansion of 
the blood volume, which is compensated by expansive erythropoiesis. As a result the total mass 
of erythrocytes is increased by 70-fold during fetal development. However, the embryo 
constantly exhibits critical hypoxia [1, 31]. The expansive manner and hypoxic background of 
fetal erythropoiesis suggests that it is similar to adult stress erythropoiesis. A striking indication 
18 
 
for the similarity is the requirement of BMP4/Smad5 signaling pathway for the expansion of 
erythroid progenitors during fetal definitive and adult stress erythropoiesis. Intriguingly, it has 
been proposed that adult stress erythropoiesis is a reactivation of mechanisms from fetal 
definitive erythropoiesis, since erythrocytes derived from adult stress erythropoiesis exhibit 
similar morphology to fetal definitive erythrocytes and accumulate fetal hemoglobin as well [1].  
 
 
Figure 4.  The erythroid lineage is differentially regulated during steady state and stress 
erythropoiesis.  Different stimuli and their effects to the erythroid lineage during steady state 
and stress erythropoiesis are illustrated. Note, during stress erythropoiesis the production of 
erythrocytes is enhanced by increased survival, increased proliferation and accelerated 
differentiation of erythroid progenitor cells.   
 
1.1.4. The erythroblastic island 
During erythropoiesis differentiating erythroblasts associate with macrophages and form 
erythroblastic islands (Fig. 5A). An erythroblastic island consists of a central macrophage 
surrounded by maturating erythroblasts, including proerythroblasts through to young 
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reticulocytes (Fig. 5B). The number of erythroblasts associated to a macrophage is variable and 
differs between species. For instance, erythroblastic islands of rats contain 5 to 10 erythroblasts, 
whereas erythroblastic islands of humans contain up to 30 erythroblasts [32]. The function of 
macrophages in erythroblastic islands includes the promotion of erythroblasts survival as well as 
regulation of proliferation and maturation [33]. In general, macrophages implement their 
regulatory function to erythroblasts in three distinct ways; by direct cell contact via surface 
molecules, by secretion of cytokines and also by promoting erythroblast / erythroblast 
interaction.  
Among others, erythroblast / macrophage interaction is mediated by the erythroblast macrophage 
protein (EMP) [33, 34]. EMP is a surface molecule, which is expressed in erythroblasts and 
macrophages and mediates interaction via homophilic binding. Remarkable, erythroblasts which 
are co-cultured with macrophages in the presence of anti EMP antibody show a significant 
decrease in proliferation, maturation and enucleation accompanied by a six fold increase in 
apoptosis. The rates of erythroblasts enucleation, maturation and apoptosis during EMP 
inhibition are similar to those of differentiating erythroblasts in the absence of macrophages [34, 
35]. This result underlines the importance of cellular interaction between erythroblasts and 
macrophages meditated by EMP.  
On the other hand, macrophages secrete cytokines such as IGF-1, TNFα and IL6, which have 
regulatory effects on erythroid cells. For instance, the presence of IGF-1 promotes proliferation 
of BFU-Es and CFU-Es, whereas TNFα is capable to inhibit erythropoiesis [32]. 
 In addition, macrophages mediate erythroblasts / erythroblasts interaction by spatial 
organization. It has been shown that homotypic signaling between erythroblasts within 
erythroblastic islands is crucial for regulating GATA-1 activity and therefore is essential for 
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proper erythroblast differentiation [32]. In conclusion, these studies show that the regulatory 
functions of macrophages are essential for proper erythropoiesis in vivo and erythroid 
differentiation in vitro.  
 
Figure 5. The erythroblastic island is a complex of erythroblasts associated to a central 
macrophage. (A) Transmission electron micrograph of an erythroblastic island isolated from rat 
bone marrow. Note the intensive cell contact between erythroblasts and the central macrophage. 
(B) Depiction of an erythroblastic island containing a central macrophage and associated 
erythroblasts. The maturation stages of associated erythroblasts range from proerythroblasts 
through to young reticulocytes. (Figures were adapted from Chasis, 2008 (ref. [32])) 
 
1.1.5. Enucleation of erythroblasts 
In mammals, three different cell types have been identified which lose their nucleus during 
differentiation; namely lens fibers, keratinocytes and erythrocytes [36]. In the erythroid lineage, 
enucleation is a hallmark of terminal differentiation. In humans approximately 2 x 106 mature 
erythrocytes arise per second [15]. Consequently, the process of erythroblast enucleation occurs 
very frequently and is also important for erythroid homeostasis. Among others, macrophages 
contribute essentially to erythroblast enucleation [33]. Since enucleation occurs in pure 
erythroblast in vitro cultures as well, it is reasonable that enucleation of erythroblasts is a cell-
autonomous process [37]. However, in the absence of supporting cells the enucleation of 
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erythroblasts is less efficient and also partially blocked. The distribution and remodeling of 
cytoskeleton components in erythroblasts during enucleation have been described many years 
ago [38]. Despite that, little is known about genes and signaling pathways which initiate and 
regulate erythroblast enucleation in a cell-autonomous manner. It was proposed that enucleation 
is a kind of asymmetric cell division, but this assumption remains to be verified [39-41]. 
In recent years, a few studies described molecular mechanisms that were required for enucleation 
of erythroblasts in a cell-autonomous manner. In line with the assumption that enucleation of 
erythroblasts is a cytokinesis-like process, it has been shown that during enucleation a contractile 
actin ring (CAR) is formed between nascent reticulocyte and the nucleus during enucleation [38]. 
The Rho-GTPases, Rac1 and Rac2, were identified to be essential for CAR formation during 
terminal differentiation as well as enucleation of erythroblasts [42]. Furthermore, it was 
demonstrated that mDia2 is the major effector of Rac1 and Rac2 in CAR formation and 
enucleation. This study revealed genes essential for regulating erythroblast enucleation in the last 
steps of erythropoiesis in a cell-autonomous manner [42].  
The tumor suppressor protein retinoblastoma (Rb) was shown to be essential for enucleation of 
erythroblasts in a cell-autonomous manner as well [43]. The authors showed that the function of 
Rb in enucleation of erythroblasts is only required during erythropoiesis under stress conditions, 
such as fetal development or anemia-induced stress erythropoiesis [43]. These results 
additionally demonstrate that enucleation of erythroblasts is differentially regulated during 
steady state and stress erythropoiesis. Despite recent findings about genes involved in 
enucleation of erythroblasts the entire process, especially during stress erythropoiesis, remains 
largely unknown. 
 
22 
 
1.2. Regulation and function of mitogen-activated protein kinases 
(MAPKs) 
2.2.1. Upstream signaling of MAPKs 
In multicellular organisms each cell is regulated by hierarchal structured systems to organize 
fundamental processes, such as development, homeostasis and survival. Therefore it is required 
that each cell is able to recognize and response to regulative signals. Major components of 
cellular mechanisms for recognition and transduction of signals are MAPKs. The regulation and 
function of MAPKs is highly conserved in eukaryotes from yeast through to mammals [44, 45]. 
In vertebrates five subfamilies of MAPKs have been described including extracellular signal-
regulated kinases ERK1/2, c-Jun N-terminal kinases JNK1/2/3, p38α/β/δ/γ, ERK5 and ERK7. 
Extracellular stimuli such as growth factors, cytokines and toxins as well as environmental 
changes including cell adherence, osmolarity and temperature result in phosphorylation and 
activation of distinct MAPKs [46, 47]. Upon activation MAPKs regulate cellular processes, such 
as metabolism, proliferation, differentiation, survival and apoptosis by phosphorylating definite 
substrates [48].   
The activation of MAPKs is regulated within MAPK signaling cascades. MAPK signaling 
cascades are integrated kinase networks and their central parts are structured in three regulative 
levels [46]. The first level consists of at least 20 MAPK kinase kinases (MKKK) and the second 
level consists of seven MAPK kinases (MKK). The third level encompasses eleven MAPKs. In 
addition, several splice variants are described for many MAPK genes. In general, extracellular 
stimuli are recognized by G-protein coupled receptors, which transduce the signals to small G-
proteins. Next, these small G-proteins activate MKKKs. Subsequently to their activation each 
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MKKK phosphorylates and activate a specific subset of MKKs. These MKKs further activate 
definite members of the MAPK families (Fig. 6). Notably, the duration and cellular localization 
of kinase activity of each MAPK is dependent on its phosphorylating upstream kinases. 
Furthermore, activity of MAPKs is modulated by protein phosphatases and scaffold proteins. 
Thus, combinatory effects within MAPK signaling cascades, modulation of kinase activity and 
most importantly different properties of each MAPK enable a precise cellular response [46]. 
 
 
Figure 6. The MAPK signaling cascades are major components of cellular signal 
transduction. Illustration of the MAPK signaling cascades including ERK1, ERK2, JNK, p38 
and ERK5 MAPK families with common upstream activators and prominent substrates. (Figure 
was adapted from Ramman, 2007 (ref. [49]) 
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1.2.2. The ERK, JNK and p38 MAPK families 
MAPKs are grouped in 5 families and are encoded by at least eleven genes, which have 
additional splice variants [47]. ERK, JNK and p38 MAPK are the best studied MAPK families, 
which might also reflect their biological significance.  
The genes of ERK1 and ERK2 are evolutionary conserved and share 83% identity [50]. Their 
main products, 44 kDa ERK1 and 42 kDa ERK2 are ubiquitously expressed. ERK1/2 regulate 
cellular processes such as proliferation, differentiation and survival. ERK1/2 are activated in 
response to growths factors, ligands for G-protein coupled receptors and cytokines. Among 
others, the upstream signaling cascade activating ERK1/2 includes small G-protein of the Ras-
family, MKKKs of the Raf-family and the MKKs MEK1 and MEK2. Substrates regulated by 
ERK1 and ERK2 encompass protein kinases such as RSK, proteins involved in cell attachment 
such as paxillin and transcriptions factors including Elk1, c-Fos and c-Myc [50]. Notably, 
perturbed regulation of ERK1/2 by mutational activation of upstream regulators plays an 
important role in oncogenic transformation. Mutational activation of EGFR, Ras and Raf is 
found in multiple human cancers, such as lung and pancreatic cancers as well as melanomas 
[51]. 
The JNK MAPKs are also referred to as stress-activated protein kinase (SAPK) and include three 
JNK genes; Jnk1, Jnk2 and Jnk3 [52]. The main products of JNK genes are expressed in a short 
(46 kDa) and a long form (54 kDa). Whereas JNK1 and JNK2 are ubiquitously expressed, JNK3 
expression is restricted to brain, heart and testis. JNKs regulate cytokine production, 
inflammatory response, programmed and stress-induced apoptosis as well as cell transformation 
and metabolism. JNKs are activated during inflammation and environmental stresses, such as 
heat shock and radiation. At least 14 of the described 20 MKKKs are capable to activate either 
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MEK4 or MEK7, which subsequently activate JNKs. Prominent substrates of JNKs are the 
transcription factors c-JUN, ATF-2, p53 and Elk-1 [52]. It has been shown that JNKs play 
different roles in multiple tumors. For instance, in 7,12-dimethylbenz(a)anthracene / 12-O-
tetradecanoylphorbol-13-acetate (DMBA / TPA)-induced skin cancer model JNK1 is capable to 
suppress tumor development, whereas JNK2 promotes papilloma formation. On the other hand, 
it has been shown recently that JNK1 but not JNK2 promotes liver cancer development by down-
regulation of p21 and up-regulation of c-myc. It remains to be determined, whether differential 
regulation of ERK, AKT and AP1 activity could explain the cell context-dependent functions of 
JNKs observed in skin and liver tumorigenesis [45].   
The p38 MAPK subfamily, termed SAPK as well, includes four isoforms; p38α, p38β, p38δ and 
p38γ. Notably, p38 isoforms share up to 40% identity with other MAPKs and only 60% of 
identity among each other.  Hence, it is reasonable that the p38 isoforms have highly diverse 
functions [49]. The isoforms p38α and p38β are expressed ubiquitously. In contrast, p38γ is most 
prominently expressed in skeletal muscles and p38δ is mainly found in testis, pancreas, kidney 
and small intestine [53]. p38α is the best studied isoform among the p38 MAPKs and will be 
discussed more detailed later (see below). Members of p38 MAPK subfamily have been shown 
to regulate cellular process such as inflammatory response, cell cycle progression, proliferation 
and differentiation. p38 MAPKs are activated in response to pro-inflammatory cytokines, UV 
radiation, osmotic shock and hypoxia. The signaling cascade activating p38 MAPKs include 
small GTP-binding proteins of the Rho-family such as Rac1, Cdc42 and Rho which activate 
MKKKs such as MLKs, ASK1, TAK1 and members of the MEKK family. Next, these MKKKs 
activate MKK3 and MKK6, which specifically activate p38 MAPKs [53]. Additionally, p38α has 
been shown to be activated by autophosphorylation upon TAB1 interaction [49]. Among others, 
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prominent substrates of p38 MAPKs are transcription factors p53 and STAT1, protein kinases 
MAPKAP2 and MNK1 and diverse proteins such as NHE1, cdc25 and TAU [53]. Recently, the 
relative contribution of the p38 isoforms (p38β, p38γ and p38δ) has been studied in myofiber 
growth and regeneration of skeletal muscle in adult mice [54]. It has been shown that p38β, p38γ 
and p38δ are dispensable for adult muscle formation and muscle regeneration after injury. 
However, chemical inhibition of p38α in either p38β, p38γ or p38δ-deficient adult primary 
myoblasts abrogated their differentiation, suggesting that p38α is the essential isoform in adult 
myogenesis [54]. 
 
1.2.3. Signal integration and cross-talks of MAPK signaling cascades  
As described before, MAPK signaling cascades are highly specific and exhibit linear signal 
transduction, which is modulated by scaffold proteins and phosphatases. Signal integration 
provides an additional way to modulate signal transduction and allows further specification of 
the cellular response. Diverse cross-talks of MAPK signaling cascades were found among each 
other as well as with other signaling pathways, such as PI3K/AKT pathway [45]. These cross-
talks are generally mediated via upstream regulators or downstream targets of MAPKs and can 
have either antagonistic or supportive effects on the signal transduction and cellular response.  
Recently, JNK- and p38-MAPK signaling pathways were found to have antagonistic effects on 
cell fate decisions [45, 55]. Whereas the MKK7-JNK pathway promotes proliferation, 
transformation, regeneration and prevents premature senescence; the MKK3/6-p38-MAPK 
pathway antagonizes these processes [55]. For instance, mkk7-deficient mouse embryonic 
fibroblasts (MEF) have impaired JNK activation, reduced cell proliferation, enhanced stress 
sensitivity and exhibit premature senescence [55, 56]. On the other hand, chemical and genetical 
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inhibition of p38-MAPK in MEFs leads to increased proliferation and prevents premature 
senescence [55, 57]. Interestingly, Wada et al. have shown that inhibition of p38-MAPK in 
mkk7-deficient MEFs could rescue the observed proliferation defects [55]. Moreover, stress 
induced premature senescence of mkk7-defcient MEFs was abolished by chemical inhibition of 
p38α/β [55]. This study nicely demonstrates the properties and cross-talks of JNK- and p38-
MAPK signaling pathway and is a good example for signal integration of MAPK signaling 
cascades. 
On the other hand MAPK signaling cascades are also linked to other signaling pathways. For 
instance, The RAS/MEK/ERK pathway intimately interacts with PI3K/AKT pathway. Strikingly, 
both pathways are regulated by RAS [58]. The interaction between RAS/MEK/ERK and 
PI3K/AKT pathway is very prominent in regulation of apoptosis. The function of 
RAS/MEK/ERK pathway to suppress apoptosis is occasionally dependent on PI3K-dependent 
signaling as demonstrated in different leukemia model cell lines [59]. Additionally, AKT has 
been reported to trigger activation of RAF1/MEK/ERK pathway by a PKC-dependent, but RAS-
independent mechanism. This mechanism was shown to be essential for the antiapoptotic effect 
of AKT in leukemia model cell lines [60].   
In consideration of the diversity of MAPK signaling cascades and the complexity of signal 
integration, there is a very high number of possible interactions. This suggests that, despite being 
intensively studied, there are still many unknown properties and functions of MAPKs.   
 
1.2.4. The function of p38α in diverse cellular processes   
p38α is the best studied MAPK of the p38 MAPK family. p38α is activated in response to pro-
inflammatory cytokines and cellular stresses, such as radiation or osmotic shocks [53]. The 
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cellular processes regulated by substrates of p38α encompass chromatin remodeling, 
transcription, mRNA stability, cytoskeleton remodeling as well as metabolism and cell cycle 
progression. Impaired regulation of p38α function implicates pathological effects such as 
inflammatory diseases, neurodegenerative disorders, cardiovascular dysfunctions, cancer and 
developmental defects (Fig. 7) [45]. 
 
 
Figure 7. p38 MAPKs are required to regulate diverse physiological processes. p38 MAPKs 
are essentially involved in the regulation of diverse physiological processes. Loss p38 MAPKs 
leads to deregulation and pathological implications of these processes. Consider that p38α was 
described to have a crucial role in most of the shown processes. (Figure was adapted from 
Cuenda, 2007 (ref.[53])) 
 
The role of p38α in inflammatory process has been studied intensively and is subject of recent 
clinical trails [61]. During inflammatory processes p38α is activated in response to endotoxins 
such as liposaccharide and pro-inflammatory cytokines including TNFα and IL-6. Subsequently 
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to its activation p38α promotes the production of cytokines such as TNFα, Il-6 and Il-8 (Fig. 
8A). Furthermore, p38α induces key inflammatory enzymes like COX2 and iNOS [61]. 
Noteworthy, p38α promotes the production of cytokines, which have been shown to activate 
p38α as well. Hence it is reasonable that p38α is part of a positive feed back loop in regulating 
cytokine production [62]. In general, p38α promotes cytokine production by transcriptional 
activation and mRNA stabilization [63, 64]. For instance, it has been shown recently that p38α is 
required for stabilization of TNFα mRNA upon Streptococcus pneumoniae infection [64]. 
Current clinical trails examine the therapeutic potential of chemical inhibitors of p38α to treat 
excessive inflammatory responses and chronic inflammation, such as rheumatic diseases and 
autoimmune diseases [61]. However, several studies demonstrate the necessity of p38α to 
negatively regulate cell proliferation. Thus chemical inhibition of p38α could also lead to 
unwanted proliferation and possibly promotes cancer development [48, 65].  
A striking example for the requirement of p38α in regulating cellular proliferation is the role of 
p38α in liver cancer development [65]. Mice with liver-specific deletion of p38α (p38α∆li) show 
enhanced liver cancer development using diethylnitrosamine (DEN)-induced hepatocellular 
carcinoma model. Upon DEN-treatment p38α∆li mice developed a higher number of liver tumors, 
which have increased size and augmented proliferation of tumor cells (Fig. 8B). Moreover, in 
this context it has been shown that p38α mediates its antiproliferative effect by antagonizing the 
JNK/c-jun pathway [65]. 
On the other hand, p38α plays a pivotal role during development and in differentiation of diverse 
stem and progenitor cells. Notably, straight knock-out of p38α (p38αKO) are embryonic lethal, 
which underlines the importance of p38α during fetal development. Embryonic lethality of 
p38αKO mice starts with the beginning of E10.5 and is thought to be a result of impaired placental 
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vascularization [66]. Nevertheless, tissue-specific deletion of p38α allows characterizing the 
function of p38α in late embryonic and postnatal development as well as in adult mice. For 
instance, mice with specific deletion of p38α in the embryo proper (p38α∆/∆) were used to 
circumvent death due to placental defects [65]. At birth p38α∆/∆ mice have similar size compared 
to their littermates. However, soon after birth p38α∆/∆ mice are retarded in growth and virtually 
all of them die within in the first week (Fig. 8C). The cause of death is most likely lung 
dysfunction [65].  
Defective differentiation of stem and progenitor cells lacking p38α has been described in 
bronchioalveolar stem cells, myoblasts, neuroblasts, adipoblasts and immune cells [67-71]. In 
adult mice p38α-deficiency in the lung leads to an increased number of stem and progenitor cells 
and an accumulation of immature progenies. In this context it has been shown that p38α is 
essential to inhibit proliferation by blocking EGFR and to promote differentiation by up-
regulating C/EBPα and HNF3β [72]. In addition, p38a∆/∆ mice exhibit increased proliferation of 
myoblasts as well as delayed growth and maturation of myofibers in the neonatal period [68]. 
Remarkable, p38a-deficient myoblasts fail to form multinucleated myotubes in vitro (Fig. 8D). 
In addition, p38a-deficient myoblasts have reduced expression of muscle differentiation-specific 
genes and show impaired cell cycle exit during differentiation [68]. These studies show, that 
p38α is required to negatively regulate proliferation and to promote differentiation in both, 
maturating bronchioalveolar stem cells and myoblasts. Hence it is reasonable to assume that this 
might also be true for progenitor cells of other tissues. However, the molecular mechanisms 
regulated by p38α during differentiation are largely unknown and most likely cell type specific. 
Additionally, it is a reasonable hypothesis that impaired development in p38α-deficient mice is a 
result of tissue-specific differentiation defects rather than a lack of morphogenic signaling. 
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Figure 8. p38α is involved in inflammation, tumorigenesis, development and 
differentiation. (A) Illustration of the regulatory function of p38α in cytokine expression. (B) 
Loss of p38α results in enhanced liver cancer development. (C) Deletion of p38α in the embryo 
proper leads to growth retardation in the neonatal period. (D) p38α-deficient myoblasts fail to 
form multinucleated myotubes in vitro. (Figures 8A was adapted from Schindler, 2007 (ref. 
[61]). Figure 8B was adapted from Hui, 2007 (ref. [48]). Figure 8C was adapted from Hui, 2007 
(ref. [65]). Figure 8D was adapted from Perdiguero, 2007 (ref. [68]) 
 
1.3. p38α is required for enucleation of erythroblasts under stress 
conditions 
Survival, proliferation and differentiation of erythroid cells is primarily regulated by Epo. Epo 
interacts with erythropoietin-receptor (EpoR), which subsequently activates diverse signaling 
pathways, such as JAK-STAT and MAPK pathways [73, 74]. Advancement in methodology, 
especially in in vitro culture systems of erythroid cells, enabled to characterize signaling 
pathways that were activated by Epo and other stimuli and to analyze their function in erythroid 
proliferation and differentiation [37].  
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JAK2 is activated by Epo and promotes proliferation of erythroid cells [75]. The role of JAK2 in 
erythroid proliferation is underlined by the JAK2 V617F mutation. This mutation causes 
constitutive activation of JAK2, leads to uncontrolled proliferation of erythroid cells and is very 
likely responsible for development of polychemia vera in humans [76]. ERK1/2, which is also 
activated by Epo, promotes proliferation of erythroid cells as well [77]. Constitutive activation of 
ERK1/2 in erythroid cells has been shown to cause prolonged Epo-independent proliferation 
[77]. Additionally, activated ERK1/2 blocks differentiation and suppresses apoptosis in erythroid 
cells [77, 78]. On the other hand, it was shown that inhibition of ERK1/2 resulted in increased 
apoptosis similar to Epo deprivation [78]. Epo signaling also leads to activation of JNK and 
p38α [79-81]. Inhibition of JNK in primary murine bone marrow cells inhibited proliferation of 
BFU-Es, but did not affect the more differentiated CFU-Es [82]. Therefore, JNK activity was 
supposed to be important for proliferation of early erythroid progenitors [82]. Several studies 
describe a critical role of p38α in erythropoiesis [83-86]. It was proposed that p38α together 
with JNK suppresses ERK during erythroid differentiation, but this assumption and its effect 
remains to be verified [84]. 
It has been previously shown that mice lacking p38α in the embryonic tissue (p38α∆/∆) or 
specifically in the hematopoietic system (p38α∆blood) have impaired enucleation of erythroblasts 
under stress conditions [Wagner lab, unpublished]. During fetal development p38α∆/∆ and 
p38α∆blood mice exhibited nucleated erythrocytes in the peripheral blood (Fig. 9A, B). 
Interestingly, within one week after birth nucleated erythrocytes in the peripheral blood 
disappeared and were not observed in healthy adult p38α∆blood mice as well (Fig. 9C). However, 
phenylhydrazine-(PHZ) induced hemolytic anemia in p38α∆blood adult mice led to the 
reappearance of nucleated erythrocytes in the peripheral blood and in the spleen (Fig. 9D, E). 
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These mice also showed a dramatically reduced population of mature erythroid cells in spleen 
upon PHZ-treatment (Fig. 9F).  Moreover, preliminary data suggested that erythroblasts 
enucleate normally in adult mice with macrophage-specific deletion of p38α upon PHZ-
treatment [Wagner lab, unpublished].  
To further analyze the role of p38α in differentiation of erythroblasts, in vitro culture system of 
fetal liver-derived erythroid progenitors (FLEP) was used. Noteworthy, p38α∆/∆ FLEPs almost 
completely failed to enucleate during in vitro differentiation (Fig. 9G). Furthermore, p38α∆/∆ 
FLEPs did not up-regulate surface markers related to terminal differentiation and exhibited 
reduced amount of hemoglobin [Wagner lab, unpublished]. These data suggest that the impaired 
enucleation of p38α∆/∆ FLEPs is accompanied by differentiation defects. Taken together, it has 
been shown that p38α is required for enucleation of erythroblasts during fetal development and 
adult stress erythropoiesis. Moreover, it is suggested from data from the Wagner lab that the 
function of p38α in enucleation of erythroblasts is cell-autonomous. 
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Figure 9. Loss of p38α affects enucleation of erythroblasts during stress erythropoiesis. (A, 
B) Blood smears of peripheral blood from p38α∆/∆, p38α∆blood and control newborn mice. (C) 
Amount of nucleated blood cells in the peripheral blood of p38α∆blood and control mice. (D, E) 
Peripheral blood smears and splenocyte cytospins from adult p38α∆blood and control mice after 
PHZ-treatment. (F) TER119 / CD71 surface marker labeling of splenocytes from p38α∆blood and 
control mice after PHZ-treatment analyzed by FACS. (G) Cytospined p38αf/+ and p38α∆/∆ 
FLEPs at 48h of differentiation. Nucleated erythrocytes are indicated by arrows. (Figures were 
obtained from Lijian Hui, Wagner lab, unpublished). 
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1.4. Goal of the diploma thesis 
The ontogeny and origins of mammalian erythropoiesis have been studied intensively and lead to 
comprehensive models. Until today there is increasing knowledge about hormonal signaling 
regulating steady state and stress erythropoiesis and new insights into molecular pathways 
essential for erythroblast differentiation. However, the molecular pathways involved in 
erythroblast differentiation, especially under stress conditions are still largely unknown.  
The goal of my diploma thesis work was to define substrates of p38α essential for erythroblast 
differentiation, to provide convincing evidence for the cell-autonomous function of p38α in 
erythroblast differentiation under stress conditions and to characterize by which molecular 
mechanism p38α regulates erythroblast enucleation. I will describe my attempts to identify 
substrates of p38α essential for erythroblast enucleation. Furthermore, I will demonstrate that the 
function of p38α in enucleation of erythroblasts is cell-autonomous using mice with tissue-
specific deletion of p38α. In addition, I demonstrate that p38α is required for regulating gene 
expression, which is characteristic for erythroid differentiation using the FLEP in vitro culture 
system. Moreover, there is aberrant activation of the retinoblastoma protein (Rb) pathway in 
p38α∆/∆ FLEPs. Noteworthy, the impaired differentiation of p38α-deficient erythroblasts is 
similar to that of erythroblasts lacking Rb, suggesting that activation of the Rb pathway by p38α 
is a key event for erythroblast differentiation, especially for enucleation under stress conditions. 
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2. Results 
2.1. Identification of p38α binding partners during erythroblast 
differentiation 
The analysis of p38α and its protein complex in differentiated erythroblasts should provide 
information about binding partners and substrates of p38α, which are likely involved in 
erythroblast enucleation. Therefore, I performed co-immunoprecipitation of phosphorylated, 
activated p38α (p-p38α) and its protein complex from protein extracts of differentiated 
erythroblasts. p-p38α antibodies were coupled to protein A-beads (p-p38α-beads) and incubated 
with protein extracts from p38αf/+ FLEPs differentiated for 24 and 48 hours. Protein extracts 
from p38α∆/∆ FLEPs were used as negative controls. p-p38α was efficiently immunoprecipitated, 
as shown by the depletion of p-p38α protein levels after co-immunoprecipitation (Fig. 10).  
Next, proteins bound to p-p38α-beads were eluted, digested in solution and analyzed by mass 
spectroscopy. Histidine ammonia lyase, beta-globin, annexin A2, S1 protein C2, junction 
plakoglobin, Ribosomal protein L37a, Ribosomal protein 29 (Rpl29) and Cathepsin G were 
identified to immunoprecipitate solely with p-p38α (Table 1). However, none of the identified 
proteins have been described to be substrates of p38α or to be involved in erythropoiesis. The 
proteins Rpl29, junction plakoglobin and annexin A2 were shown to be involved in cell 
proliferation, differentiation and cytoskeleton remodeling [87-90] and may be of interest to be 
further characterized in erythroblast differentiation.  
The FLEP in vitro culture system provided only a limited amount of protein extracts, which 
might also be reflected by the low number of detected peptides per protein. Thus, this experiment 
does not provide convincing data on p38α substrates and binding partners. To obtain more 
protein extract of differentiated erythroblasts, I planed to establish an in vitro culture system of 
embryonic stem (ES) cell-derived erythroid progenitors (ESEP). 
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Gene symbol 
  MW p38αf/+ p38α∆/∆ 
Gene name (kDa) 24h 48h 24h 48h 
Mapk14 p38α 41 3 12 0 0 
HaI Histidine ammonia lyase 72 5 0 0 0 
Hbb-bI Beta-globin 16 4 0 0 0 
Anxa2 Annexin A2 39 3 0 0 0 
Hnrnpab S1 protein C2 36 2 0 0 0 
Jup Junction plakoglobin 82 2 0 0 0 
Rpl37a Ribosomal protein L37a 11 0 2 0 0 
Rpl29 Ribosomal protein 29 18 0 2 0 0 
Ctsg Cathepsin G 29 0 2 0 0 
 
Table 1. Proteins immunoprecipitated with p-p38α. p-p38α and its protein complex were 
immunoprecipitated from protein extracts of p38αf/+ differentiated for 24h and 48h. p38α∆/∆ 
FLEPs were used as negative controls. The immunoprecipitate was digested in solution and 
analyzed by mass spectroscopy. The “numbers” describe the number of different peptides 
detected per protein. MW, molecular weight. 
 
 
 
 
          
 
 
Figure 10. Protein levels of p-
p38α are decreased after co-
immunoprecipitation. Western 
Blot analysis of p-p38α protein 
levels in p38af/+ and p38a∆/∆ FLEP 
protein extracts before and after 
immunoprecipitation of p-p38α; β-
actin was used as a loading control.  
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2.2. Establishment of ESEP in vitro culture system for mass 
cultivation of erythroid cells 
The in vitro culture system of FLEPs is an excellent tool to study differentiation of erythroblasts 
up to mature erythrocytes. However, the expansion of FLEPs is limited and the low cell number 
hindered the analysis of substrates and binding partners of p38α by co-immunoprecipitation. 
Previously it was shown, that the ES-derived, ESEP in vitro culture system provides virtually 
unlimited supply of erythroid cells [91]. Therefore, I next tried to establish an in vitro culture 
system of wild-type and p38α-deficient ESEPs. 
 
2.2.1. Differentiation of p38α+/+ and p38α-/- ES cells into ESEPs 
To obtain wild-type and p38α-deficient ESEPs, p38α+/+ and p38α-/- ES cells were subjected to a 
two step protocol for directed differentiation as described [91]. Briefly, differentiation of ES 
cells was induced by withdrawal of leukemia inhibitory factor (LIF) and addition of 
differentiation promoting factors, such as human transferrin. Simultaneously, ES cells were 
plated on non-coated Petri dishes to allow formation of embryoid bodies (EBs). At day 6 of 
differentiation, EBs were dissociated into single cells and cultivated in erythroblast proliferation 
medium to expand erythroid progenitors. 
After induction of differentiation both, p38α+/+ and p38α-/- ES cells, formed EBs at day 2 to 3, 
which continuously increased in size up to day 6. The p38α+/+ EBs appeared to be roundish with 
a smooth surface. At day 5 the inner cell mass of p38α+/+ EBs turned brown and slightly reddish 
(Fig. 11A). In contrast, p38α-/- EBs had irregular oval-shape and outgrowing cells on the surface, 
which detached during pipetting and reappeared on the following day. From day 4 onwards, the 
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inner cell mass of p38α-/- EBs appeared to be black (Fig. 11A). Next, these EBs were dissociated 
into single cells and cultivated in erythroblast proliferation medium. After 7 hours of cultivation 
in erythroblast proliferation medium the culture of dissociated p38α+/+ EBs showed adherent 
cells morphologically resembling neurons, myocytes and fibroblasts as well as erythroblasts in 
suspension (Fig. 11B). From this culture, a pure p38α+/+ ESEPs culture was obtained after 4 
days. However, the culture of dissociated p38α-/- EBs showed no adherent cells and mainly cell 
clumps with only few erythroblast-like cells in suspension (Fig. 11B). Furthermore, it was not 
possible to obtain a p38α-/- ESEP culture from these cells.  
Previously, p38α has been described to be involved in differentiation of different cell types, such 
as myoblasts and lung stem cells [72, 92]. The lack of adherent cells and the impaired expansion 
of erythroid progenitors suggested that loss of p38α affected ES cell differentiation in vitro. 
Therefore, I analyzed the erythroid lineage in p38α+/+ and p38α-/- EBs at day 6 of differentiation. 
Interestingly, FACS analysis showed a markedly increased population of immature c-KIThigh 
(49.4%) and CD71high  (79.2%) cells in p38α-/- EBs compared to p38α+/+ EBs (36% and 68%, 
respectively) (Fig. 12A, B). TER119, a surface marker of mature erythroid cells, was not 
detected in p38α+/+ and p38α-/- EBs (Fig. 12B). These data indicate that p38α-/- EBs appear to 
have differentiation defects of erythroid progenitors. Moreover, the complete lack of adherent 
cells in the culture of dissociated p38α-/- EBs suggests that p38α has an essential role in the 
differentiation of ES cells into the erythroid lineage in vitro. 
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Figure 11.  p38a-/- ES cells form EBs with aberrant morphology.  (A) p38a+/+ and p38a-/- ES 
cells differentiated into EBs for 4, 5 and 6 days. Arrows indicate outgrowing cells on the surface 
of p38a-/- EBs.  (B) Culture from dissociated  p38a+/+ and p38a-/- EBs cultivated in erythroblast 
proliferation medium for 7 hours. Erythroblasts are indicated as “*”. Note that mainly cell 
clumps, few erythroblast-like cells and no adherent cells were observed in the p38a-/- culture.  
 
               
Figure 12. p38a-/- EBs show 
an increased population of 
immature erythroid cells. 
(A, B) Surface markers of 
cells from dissociated 
p38a+/+ and p38a-/- EBs were 
labeled with c-KIT (A) and 
CD71 / TER119 (B); labeled 
erythroid cells were analyzed 
by FACS.  
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2.2.2. Deletion of p38α floxed alleles in ESEPs 
p38α-/- ES cells showed impaired erythroid differentiation, which is likely due to the lack of 
p38α. To circumvent defective ES cell differentiation caused by loss of p38α, I generated ES 
cells with p38α floxed alleles (p38αf/f). I planed to differentiate p38αf/f ES cells into ESEPs and 
subsequently delete p38α floxed alleles in ESEPs. I initialized two approaches for the deletion of 
p38α floxed alleles, which are an inducible system using CreER(T2) and lentiviral-mediated 
expression of iCre [93, 94]. 
Deletion using CreER(T2): This  gene encodes a Cre recombinase (Cre) fused to a mutant 
estrogen ligand-binding domain (ER(T2)). Recombinase activity of Cre is blocked by ER(T2), 
but is restored by blocking the inhibitory function of ER(T2) with tamoxifen [93]. I planed to 
generate a stable p38αf/f/CreER(T2) ES cell line, differentiate these cells into ESEPs and delete 
p38α floxed alleles in ESEPs by tamoxifen treatment. I constructed a lentiviral vector containing 
CreER(T2) and a puromycin resistance gene; both genes under the control of hPGK promoters 
(pL4.hPGK.CreER(T2).hPGK.puro) (Fig. 13A). p38αf/f ES cells were infected with 
pL4.hPGK.CreER(T2).hPGK.puro lentiviral particles for two days. Afterwards, p38αf/f ES cells 
were selected for positive infection by addition of 1.5 µg/ml puromycin to the medium for 3 
days. A p38αf/f/CreER(T2) ES cell line was established from a single clone. To characterize the 
deletion efficiency of CreER(T2), p38αf/f/CreER(T2) ES cells were treated with  1 µmol/ml 
tamoxifen for 2 days. PCR analysis confirmed efficient integration of CreER(T2) into the 
genome of p38αf/f ES cells (Fig. 13B). However, no deletion of the p38α floxed alleles were 
detected (Fig. 13C). These data unfortunately imply that CreER(T2) did not exert recombinase 
activity upon tamoxifen treatment, likely due to insufficient expression levels or gene mutations. 
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Deletion using iCre: For the second approach I tried to delete the p38α floxed alleles in ESEPs 
by lentiviral-mediated iCre expression. I was able to infect wild-type ESEPs efficiently using 
pRRLSIN.cttp.hPGK.GFP lentiviral particles (Fig. 14A). Next I had to replace GFP in 
pRRLSIN.cttp.hPGK.GFP by IRES.GFP (pSS.hPGK.IRES.GFP) and insert iCre afterwards 
(pSS.hPGK.iCre.IRES.GFP) (Fig. 14B). To obtain p38af/f ESEPs, p38af/f ES cells were subjected 
to directed differentiation as shown before. There was no obvious phenotype during p38af/f ES 
cell differentiation and a pure p38af/f ESEP culture was established. The p38af/f ESEPs showed 
properties similar to wild-type ESEPs and were not further characterized. For deletion of the 
p38α floxed alleles, ESEPs were infected with pSS.hPGK.iCre.IRES.GFP lentiviral particles; 
pSS.hPGK.IRES.GFP lentiviral particles were used as control. The infection efficiency of ESEPs 
was approximately ~70%, as determined by fluorescence microscopy. PCR analyses confirmed 
integration of iCre into the genome of p38αf/f ESEPs (Fig. 14C). Moreover, there was efficient 
deletion of the p38α floxed alleles (Fig. 14C). However, p38af/f ESEP cultures expressing iCre 
died within a few days after infection, whereas the control culture could be expanded. These data 
suggest that lentiviral-mediated expression of iCre had toxic effects in ESEP cultures. It was 
shown previously that high expression levels of Cre can lead to genotoxic effects in proliferating 
mammalian cells [95]. Taken together, it was not possible for me to obtain p38α-deficient 
ESEPs from p38α-/- and p38αf/f ES cells.  
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Figure 13. CreER(T2) does not exert recombinase activity in p38αf/f/CreER(T2) ES cells. 
(A) Vector map illustrates pL4.hPGK.CreER(T2).hPGK.puro lentivirus vector. (B) PCR analysis 
of CreER(T2) in p38αf/f/CreER(T2) ES cells. (C) p38α floxed and p38α deleted alleles in 
p38αf/f/CreER(T2) ES cells upon Tamoxifen (Tam) treatment were analyzed by PCR. 
pL4.hPGK.CreER(T2).hPGK.puro plasmids and mouse genomic DNA with p38α floxed and 
deleted allele were used as positive controls, H2O was used as negative control. 
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Figure 14. iCre deletes p38α floxed alleles in p38αf/f ESEPs. (A) GFP expression of wt ESEPs 
infected with pRRLSIN.cttp.hPGK.GFP lentiviral particles (ESEP+GFP) analyzed by FACS. 
Non-infected ESEPs were used as control (ESEP-Ctl) (B) Vector map illustrates 
pSS.hPGK.iCre.IRES.GFP lentivirus vector. (C) iCre, p38α floxed and p38α deleted alleles in 
p38αf/f ESEPs infected with pSS.hPGK.IRES.GFP (p38αf/f+Ctl) and pSS.hPGK.iCre.IRES.GFP 
(p38αf/f+icre) lentiviral particles were analyzed by PCR. pSS.hPGK.iCre.IRES.GFP plasmids 
and mouse genomic DNA with p38α floxed and deleted allele were used as positive controls, 
H2O was used as negative control. 
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2.3. Identification of p38α substrates by p-p38α in vitro kinase assay 
A p-p38α in vitro kinase assay was initiated previously in the Wagner lab by Lijian Hui in 
collaboration with Eleanor Coffey; Centre for Biotechnology, Turku to identify substrates of 
p38α during erythroblast differentiation. Proteins extracts from FLEPs cultured in differentiation 
medium for 0h and 30h were incubated with purified p-p38α and radiolabeled ATP. The proteins 
were separated on a 2D gel and visualized by silver staining. Phosphorylation levels of proteins 
were detected by radiography (Fig. 15). Highly phosphorylated protein spots were analyzed by 
mass spectroscopy. Potential substrates of p38α among the proteins identified by mass 
spectroscopy analyses were assigned by Eleanor Coffey Lab and are listed in Table 2A, B. The 
nuclear distribution gene C (NUDC) is described to be activated upon phosphorylation and 
involved in cytokinesis [96, 97]. As enucleation of erythroblasts is supposed to resemble 
asymmetric cytokinesis, NUDC was an attractive potential substrate of p38α that might play a 
role in erythroblast enucleation [39-41]. 
            
Figure 15. Proteins from p-
p38α in vitro kinase assay 
show high phosphorylation 
levels. (A, B) Protein extracts 
from FLEPs differentiated for 
0h (A) and 30h (B) were 
incubated with p-p38α protein 
and radiolabeled ATP. Proteins 
were separated on 2D gels, 
stained by silver staining (right 
panel) and phosphorylation 
levels were determined by 
radiography (left panel). 
Numbered circles indicate 
protein spots of interest; MW, 
molecular weight. 
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Spot Symbol Gene name 
1 STMN1 Stathmin 
2 NUDT5 ADP-sugar pyrophosphatase 
2 CLIC1 Chloride intracellular channel protein 1 
2 PSB4 Proteasome subunit beta type 4 precursor 
3 GALK 1 Galactokinase 
4 no significant hits 
5 NUCKS Nuclear ubiquitous casein and cyclin dependent kinases substrate 
6 no significant hits 
7 NPM1 Nucleophosmin  
8 NPM1 Nucleophosmin 
8 EF1D Elongation factor 1 delta 
9 CCT5 TCPE T-complex protein 1 subunit epsilon 
10 ATP5H ATPsynthase D chain, mitochondrial 
 
Spot Symbol Gene name 
1 ALB Albumin 
2 no significant hits 
3 no significant hits 
4 STMN1 Stathmin  
5 no significant hits 
6 NPM1 Nucleophosmin 
6 EF1D  Elongation factor 1 delta 
7 GALK1 Galactokinase  
7 TMOD3 Tropomodulin 3 
7 NUDC  Nuclear distribution gene C  
7 NUCKS  Nuclear ubiquitous casein and cyclin dependent kinases substrate 
8 PRDX2 Peroxiredoxin-2   
8 STRAP Serine- threonine kinase receptor associated protein  
8 GALK 1 Galactokinase  
9 no significant hits 
10 PSM6 26S protease regulatory subunit 6A  
11 HSP90B Heat shock protein 90, isoform b 
12 ATP5H ATP synthase D chain , mitochondrial 
12 LYSCP Lysozyme C type P precursor 
12 G3BP1 ras GTPase activating protein binding protein 1  
 
Table 2. Proteins identified as potential p38α substrates by p-p38α in vitro kinase assay. p-
p38α in vitro kinase assay was performed with protein extracts from FLEPs differentiated for 0h 
(A) and 30h (B). Highly phosphorylated protein spots were analyzed by mass spectroscopy and 
potential substrates of p38α are listed.  
A 
B 
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2.4. Knock-down of NUDC did not affect erythroblast enucleation 
NUDC was identified as a potential substrate of p38α by the p-p38α in vitro kinase assay using 
protein extract from differentiated FLEPs. Previously NUDC was shown to be activated upon 
phosphorylation and to play multiple roles in mitosis and cytokinesis in cultured mammalian 
cells [96, 97]. Hence, it was of interest to further characterize the function of NUDC in 
erythroblast enucleation. I applied shRNA-mediated knock-down of NUDC in wild-type FLEPs 
(FLEP sh-NUDC). Non-targeting shRNA was used as control (FLEP sh-Ctl). The efficiency of 
NUDC knock-down was shown by reduced NUDC protein level (Fig. 16A). FLEP sh-NUDC 
and FLEP sh-Ctl cells were subjected to differentiation and erythroblast enucleation was 
determined at 48 hours of differentiation. Interestingly, NUDC knock-down had no negative 
effects on the enucleation of erythroblasts (Fig. 16B). These data imply that NUDC is likely 
dispensable in erythroblast enucleation. Additionally, there were no obvious differentiation 
defects observed in NUDC-deficient FLEPs. 
 
 
Figure 16. NUDC knock-down apparently does not affect erythroblast enucleation. (A) 
Western blot analysis of NUDC protein level in FLEP sh-Ctl and FLEP sh-NUDC cells; β−actin 
was used as loading control. (B) Benzidine stained cytospins of FLEP sh-Ctl and FLEP sh-
NUDC at 48h of differentiation. (C) Amount of nucleated erythrocytes was quantified. *P < 
0.05, Student’s t test. Data are expressed as mean ± SD. ns, non significant. 
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2.5. p38α promotes enucleation of erythroblasts in a cell-autonomous 
manner 
During differentiation erythroblasts form blood islands together with macrophages, which 
facilitates the maturation and enucleation of erythroblasts [33]. It has been shown that perturbed 
function of macrophages results in defective erythropoiesis including impaired enucleation [33, 
34, 98]. Hence it is crucial to specify whether the function of p38α in erythroblast enucleation 
during fetal development and stress erythropoiesis is required either in erythroblasts or 
macrophages.  
To this end I crossed p38αf/f mice with ErGFPcre mice for specific deletion of p38α in the 
erythroid lineage (p38αf/f/ErGFPcre; p38α∆ery). I analyzed p38α∆ery mice in comparison to mice 
with specific deletion of p38α in macrophages (p38αf/f/Lysm-cre; p38α∆mΦ).  
The specificity and efficiency of Lysm-cre-mediated deletion of p38α floxed alleles was 
characterized by Lijian Hui in our lab [Wagner lab, unpublished]. To characterize the function of 
ErGFPcre, I isolated bone morrow cells from p38α∆ery mice. The bone marrow cells were 
fractionized into erythroblasts, macrophages and undefined cells by FACS sorting using surface 
marker labeling specifically for erythroid cells and macrophages (TER119 and CD71 and 
MAC1, respectively).  The specificity and efficiency of ErGFPcre-mediated deletion of p38α 
floxed alleles in the erythroid lineage is shown by PCR analysis (Fig. 17). 
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Both p38α∆ery and p38α∆mΦ newborn mice were viable and did not exhibit obvious phenotypes, 
such as inflammatory disease or anemia; the adult mice were apparently healthy as well. During 
fetal development the rapid growth of the embryo requires expansive erythropoiesis, which is 
similar to adult stress erythropoiesis [24, 99]. Thus, effects of erythropoiesis under stress 
conditions can be examined in newborn mice. I analyzed peripheral blood from newborn mice at 
postnatal day 1 (P1). Interestingly, p38α∆ery, but not p38α∆mΦ newborn mice exhibited nucleated 
erythrocytes in the peripheral blood (Fig.18 A, D). These initial observations suggested that the 
function of p38α is cell-autonomous.  
Previously it has been shown, that healthy adult p38α∆blood mice do not exhibit nucleated 
erythrocytes in the peripheral blood. However, PHZ-induced anemic stress erythropoiesis in 
adult p38α∆blood mice implicated defective enucleation of erythroblasts accompanied by a 
dramatically reduced population of mature CD71low/TER119high erythroid cells in the spleen 
[Wagner lab, unpublished]. I asked whether this phenotype is also observed in either p38α∆ery or 
p38α∆mΦ adult mice. Neither p38α∆ery nor p38α∆mΦ healthy adult mice showed nucleated 
erythrocytes in the peripheral blood. However, there was a reappearance of nucleated 
erythrocytes in the peripheral blood of adult p38α∆ery mice upon PHZ treatment (Fig. 18B). 
Additionally, up to 30% of the erythrocytes in the spleen were nucleated in these mice (Fig. 18C, 
Figure 17. p38α floxed allele is specifically and efficiently 
deleted in the erythroid lineage of p38α∆ery mice. Surface 
marker of bone marrow cells from p38α∆ery mice were 
labeled with MAC1 and CD71/TER119. Bone marrow cells 
were fractionized into macrophages, erythroid and 
undefined cells by FACS sorting (MAC1+, CD71+/TER119+ 
and MAC1-, CD71-, TER119-, respectively). p38α floxed 
and p38α deleted allele were analyzed by PCR.  
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G). In contrast, these effects of PHZ-induced anemia were not observed in p38α∆mΦ mice, which 
showed stress erythropoiesis similar to control mice (Fig. 18D, E, F, H). Interestingly, the 
significantly reduced population of mature CD71low/TER119high erythroid cells in the spleen of 
p38α∆blood mice after PHZ treatment could not be seen in p38α∆ery and p38α∆mΦ mice. This cell 
population was also reduced in control mice after PHZ treatment compared to previous findings 
(Fig. 19A, B; Fig. 9F, respectively) [Wagner lab, unpublished]. The differences observed in 
control mice could be explained by variations in the experimental procedure and the genetic 
background.  
Taken together, these data show that p38α promotes erythroblast enucleation during fetal 
development and stress erythropoiesis in a cell-autonomous manner. Moreover, these data 
suggest that the function of p38α to promote erythroblast enucleation is dispensable in 
macrophages. 
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Figure 18. p38α promotes enucleation of erythroblasts during stress erythropoiesis in a 
cell-autonomous manner. (A, B, D, E) Peripheral blood smears of p38α∆ery (A) and p38α∆mφ 
(D) newborns at P1, p38α∆ery (B) and p38α∆mφ (E) mice at day 6 after PHZ treatment and control 
mice were benzidine stained. Nucleated erythrocytes are indicated by arrows. (C, F) Benzidine 
stained splenocyte cytospins of p38α∆ery (C) and p38α∆mφ (F) and control mice at day 6 after 
PHZ treatment. (G, H) Nucleated erythrocytes in the spleen of p38α∆ery (G) and p38α∆mφ (H) and 
control mice after PHZ treatment were quantified. *P < 0.05, Student’s t test. Data are expressed 
as mean ± SD.  
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2.6. Loss of p38α and chemical inhibition blocks enucleation of 
erythroblasts in vitro 
As described before, p38α∆/∆ fetal liver-derived erythroid progenitors (FLEPs) almost completely 
fail to enucleate during in vitro differentiation [Wagner lab, unpublished]. To further confirm the 
role of p38α in enucleation of erythroblasts, I used ESEP in vitro culture system [91]. I applied 
shRNA-mediated knock-down of p38α in wild-type ESEPs (ESEP sh-p38α). Non-targeting sh-
RNA was used as a control (ESEP sh-Ctl). The efficiency of p38α knock-down was shown by 
decreased p38α protein level (Fig. 20A). As expected, the knock-down of p38α led to a 
significant increase of nucleated erythrocytes (91.8%) at 48h of differentiation, compared to 
ESEP sh-Ctl (66.7%) (Fig. 20B, C). 
I also examined whether chemical inhibition of p38α kinase activity is sufficient to block 
enucleation of erythroblasts. Addition of 1µM SB202190 inhibitor to differentiating wild-type 
ESEPs from either 0h to 48h or 24h to 48h of differentiation resulted in a substantial increase of 
nucleated erythrocytes (96% and 76%, respectively) compared to untreated wild-type ESEPs 
Figure 19. Similar 
maturation stages of splenic 
erythroid cells in p38α∆ery 
and p38α∆mφ mice after 
PHZ-treatment. (A, B) 
Surface marker of 
splenocytes from p38α∆ery 
(A) and p38α∆mφ (B) and 
control mice at day 6 after 
PHZ treatment were labeled 
with TER119 / CD71. 
Labeled splenocytes were 
analyzed by FACS. 
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(53.5%) (Fig. 20D, E). These results further demonstrate that loss of p38α and its kinase activity 
blocks enucleation of erythroblasts in vitro. Moreover, the data imply that the function of p38α to 
promote erythroblast enucleation appears to be required at late stages of differentiation, since 
inhibiting the kinase activity of p38α after 24h of differentiation is sufficient to block 
enucleation.  
 
Figure 20. Enucleation of ESEPs is blocked by p38α-knock-down and inhibition of p38α 
kinase activity in vitro.  (A) Western blot analysis of p38α protein level in ESEP sh-Ctl and 
ESEP sh-p38α cells. β−actin was used as loading control. (B) Benzidine stained cytospins of 
ESEP sh-Ctl and ESEP sh-p38α at 48h of differentiation. (C) Amount of nucleated erythrocytes 
was quantified. (D, E, F) Benzidine stained cytospins of wild-type ESEPs treated with DMSO 
(D), 1µM SB202190 from 0h to 48h (E) and 1µM SB202190 from 24h to 48h. (F) Amount of 
nucleated erythrocytes was quantified. *P < 0.05, Student’s t test. Data are expressed as mean ± 
SD. 
54 
 
2.7. Expression analysis of p38α-dependent genes regulating 
erythropoiesis 
Myoblasts lacking p38α exhibit impaired expression of differentiation-related genes during in 
vitro differentiation [68]. To verify whether p38α is also involved in regulating gene expression 
during erythroblast differentiation, I analyzed microarray data using “Gene Set Enrichment 
Analysis” (GSEA) software and performed qRT-PCR of differentiating p38αf/+ and p38α∆/∆ 
FLEPs.  
GSEA analyses gene expression profiles and determines whether defined sets of genes are 
differently expressed between two biological states [100, 101]. Here I analyzed, whether distinct 
sets of genes are either up- or down-regulated in p38α∆/∆ FLEPs compared to p38αf/+ FLEPs at 
36h of differentiation. GSEA analysis revealed that a set of genes that has been shown to be 
enriched in early hematopoietic progenitor cells, including c-Myb and Parp1 was significantly 
up-regulated in p38α∆/∆ FLEPs (Fig. 21A). Accordingly, genes that have been shown to be 
enriched in mature hematopoietic cells, such as Tmpo and Nix were down-regulated in p38α∆/∆ 
FLEPs at the same point of time (Fig. 21B) [102]. Moreover, there was reduced expression of 
predicted Gata1 and experimentally proven C/EBP target genes in p38α∆/∆ FLEPs (Fig. 21C, D) 
[103, 104]. To further determine the expression of genes indicating erythroid differentiation, I 
analyzed expression levels of hemoglobins using qRT-PCR. Indeed, p38α∆/∆ FLEPs exhibited 
reduced expression of primitive and definitive hemoglobin isoforms Hba-a1, Hba-ax Hbb-b1, 
Hbb-b2, Hbb-bh1, and Hbb-by at 48h of differentiation (Fig. 21E).  
Next, I asked whether the reduced expression of differentiation-related genes was due to 
deregulated expression of transcription factors regulating erythroid differentiation. Intriguingly, 
mRNA levels of the transcription factors Gata1, C/EBPα and Gfi-1, which are generally up-
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regulated during erythroid differentiation, were reduced p38α∆/∆ FLEPs during differentiation 
(Fig. 22A, B, C). On the other hand, Gata2 and Fli-1, which are normally expressed in early 
erythroid progenitors and down-regulated during differentiation, were increased in p38α∆/∆ 
FLEPs during differentiation (Fig 22D, E). In conclusion, these data demonstrate that p38α is 
required for regulating gene expression characteristic for erythroid differentiation. Furthermore, 
these data show that p38α has a key function in regulating erythroid differentiation under stress 
conditions. 
      
Figure 21. p38α is 
involved in regulating 
the expression of 
differentiation-related 
genes.  
(A-D) GSEA profiles of 
microarray data from 
p38af/+ versus p38a∆/∆ 
FLEPs at 36h of 
differentiation 
demonstrating relative 
expression of genes 
enriched in early 
hematopoietic progenitors 
(A), enriched in mature 
hematopoietic cells (B), 
predicted Gata1 (C) and 
experimental C/EBP (D) 
target genes. (E) Relative 
mRNA level of Hbb-b1, 
Hbb-b2, Hbb-bh1, Hbb-
by, Hba-a1 and Hba-ax in 
p38af/+ and p38a∆/∆ FLEPs 
at 48h of differentiation 
was quantified by qRT-
PCR. Data are expressed 
as mean ± SD. 
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Figure 22. Transcription factors regulating erythroid differentiation are differently 
expressed in p38α ∆/∆ FLEPs. (A-E) qRT-PCR analysis to quantify relative mRNA expression 
of Gata1 (A), C/EBPα (B), Gfi-1 (E), Gata2 (D) and Fli-1 (E) in p38af/+ and p38a∆/∆ FLEPs 
during differentiation. Data are expressed as mean ± SD. 
 
 
2.8. Defective activation of the Rb pathway in p38α-deficient 
erythroblasts  
The impaired enucleation phenotype of p38α-deficient erythroblasts is similar to that of 
erythroblasts lacking Rb [43]. Therefore, I investigated whether p38α is required to regulate the 
Rb pathway during erythroid differentiation.  
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GSEA analysis of microarray data showed, that genes which are repressed by Rb and p16 were 
significantly up-regulated in p38α∆/∆ FLEPs at 36h of differentiation (Fig. 23A) [105]. 
Importantly, Western blot analysis of total Rb-protein showed an increased level of 
hyperphosphorylated and thereby inactivated Rb-protein in p38α∆/∆ FLEPs at 24h of 
differentiation (Fig. 23B). Furthermore, a prominent function of Rb is to repress the activity of 
E2F transcription factors [106]. Accordingly, E2F-1 target genes such as Cyclin E1, Cdk2 and 
Pcna are expected to be up-regulated in case of impaired activation of the Rb pathway [107]. 
Indeed, targets genes of E2F-1 were up-regulated in p38α∆/∆ FLEPs at 36h of differentiation (Fig. 
23C).   
Next I asked whether upstream regulators of Rb were also affected by p38α-deficiency during 
erythroblast differentiation. p53, p21 and p27 are upstream regulators of Rb [108, 109]. Indeed, 
mRNA and protein levels of p53, p21 and p27 were reduced in differentiating p38α∆/∆ FLEPs 
(Fig. 23D, E). Moreover, mRNA levels of p21 and mdm2, target genes of p53 were dramatically 
reduced, suggesting a diminished activity of p53 in p38α∆/∆ FLEPs during differentiation (Fig. 
23E). These data show that p38α is required for specific activation of the Rb pathway during 
erythroid differentiation. Moreover, the phenotypic similarities to Rb-deficient erythroblasts 
suggest that activation of the Rb pathway appears to be a major function of p38α in regulating 
erythroblast differentiation, especially enucleation. 
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Figure 23. Defective activation of the Rb pathway in p38α∆/∆ FLEPs during differentiation.  
(A, B) Relative expression of genes repressed by Rb and p16 (A) and experimental E2F target 
genes (B) in p38af/+ compared to p38a∆/∆ FLEPs at 36hrs of differentiation analyzed by GSEA. 
(C) Western blot analysis to quantify protein and phosphorylation level of total Rb in p38af/+ and 
p38a∆/∆ FLEPs during differentiation. β-actin was used as loading control. (D) Protein levels of 
p53, p21 and p27 in p38af/+ and p38a∆/∆ FLEPs during differentiation were quantified by 
Western blot analysis. β-actin was used as loading control. (E) Relative mRNA expression levels 
of p53, mdm2, p21, and p27 in p38af/+ and p38a∆/∆ FLEPs at 36h of differentiation quantified by 
qRT-PCR. Data are expressed as mean ± SD. 
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2.9. p38α-deficient erythroblasts have delayed cell cycle exit 
During terminal erythroid differentiation, erythroblasts undergo cell cycle exit and accumulate in 
G0/G1 phase [110]. A basic function of Rb is to regulate cell cycle progression [111]. The 
aberrant activation of the Rb pathway implicates that p38α-deficient erythroblasts may have 
impaired cell cycle exit during terminal differentiation. Therefore, I analyzed the cell cycle 
distribution of p38αf/+ and p38α∆/∆ FLEPs during differentiation using bromodeoxyuridine 
(BrdU) / propidium iodide (PI) double staining analyzed by FACS. 
Indeed, p38α∆/∆ FLEPs had increased BrdU incorporation at 36h of differentiation, whereas 
p38αf/+ FLEPs already exhibited highly reduced BrdU incorporation and accumulated in GO/G1 
phase (Fig. 24). However, after 48h of differentiation p38α∆/∆ FLEPs stopped BrdU 
incorporation and accumulated in G0/G1 phase as well (Fig. 24). The final accumulation of 
p38α∆/∆ FLEPs in G0/G1 phase indicates that p38α-deficiency results in delayed cell cycle exit. 
In conclusion, these results demonstrate that p38α is required for regulating cell cycle exit during 
terminal differentiation and further confirm the attenuated activity of the Rb pathway in p38α∆/∆ 
FLEPs. 
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Figure 24. p38α∆/∆ FLEPs show delayed cell cycle exit. (A) BrdU / PI double staining of 
p38αf/+ and p38α∆/∆ FLEPs at 3, 24, 36 and 48h of differentiation. BrdU / PI double stained 
FLEPs were analyzed by FACS. (B) Percentage of BrdU positive p38αf/+ and p38α∆/∆ FLEPs at 
3, 24, 36 and 48h.  
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3. Discussion   
This is the first study describing the specific role of p38α in murine erythropoiesis and 
erythroblast enucleation employing 4 different genetic mouse models as well as in vitro culture 
systems using erythroblast differentiation into mature erythrocytes. It was recently reported that 
p38α plays a role in erythroid maturation in vivo and in vitro [85, 86, 112] and that p38α is 
required for enucleation of erythroblasts during fetal development and adult stress erythropoiesis 
[Wagner lab, unpublished]. Preliminary unpublished data suggested that the function of p38α is 
likely cell-autonomous. Differentiation defects such as reduced hemoglobinization and aberrant 
expression of TER119 and CD71 surface marker have been identified in p38α∆/∆ FLEPs, 
suggesting that p38α has a function in regulating erythroblast differentiation [Wagner lab, 
unpublished]. Here, I showed that the function of p38α in enucleation of erythroblasts is cell-
autonomous using mice with deletion of p38α specifically in the erythroid lineage. In addition, I 
was able to demonstrate that p38α-deficient erythroblasts exhibited diminished differentiation 
due to deregulated gene expression. Moreover, p38α-deficient erythroblasts have an attenuated 
activation of the Rb pathway likely due to reduced protein levels of p53, p21 and p27. The 
delayed cell cycle exit during terminal differentiation of p38α-deficient erythroblasts is likely 
caused by aberrant activation of the Rb pathway.  
Previously it was shown that Rb-deficient erythroblasts have impaired differentiation, defective 
cell cycle exit and, most strikingly, blocked enucleation under stress conditions [43]. These data 
suggest that p38α is required to activate the Rb pathway to promote erythroblast differentiation, 
cell cycle exit and enucleation during stress erythropoiesis (Fig.25).  
62 
 
 
Figure 25. Proposed model of p38α-dependent regulation of differentiation, cell cycle exit 
and enucleation of erythroblasts under stress conditions. (A) p38α positively regulates p53, 
p21 and p27 resulting in inhibition of CDKs and subsequently in activation of Rb; activated Rb 
promotes differentiation, cell cycle exit and enucleation of erythroblasts under stress conditions. 
(B) In the absence of p38α I found down-regulation of p53, p21 and p27, which leads to 
increased CDK activity as shown by hyperphosphorylated and inactivated Rb. Lack of Rb 
activity results in diminished differentiation, impaired cell cycle exit and blocked enucleation of 
erythroblasts under stress conditions. “green”, active protein; “red”, inactive protein; “blue”, 
processes promoted; “grey” processes not promoted. 
  
3.1. Analysis of p38α binding partners and substrates 
To characterize binding partners and substrates of active p38α during erythroblast 
differentiation, I performed co-immunoprecipitation of p-p38α. p-p38α was efficiently 
immunoprecipitated and the lack of p-p38α in the negative control confirmed it. Mass 
spectroscopy identified proteins, which solely precipitated with p-p38α. However, there were 
B A 
63 
 
also proteins identified, which solely precipitated with p-p38α-beads in the negative control. 
None of the identified proteins were described to be substrates of p38α or to be involved in 
erythropoiesis. Moreover, the number of peptides identified per protein was quite low, which is 
very likely a reflection of the limited amount of protein extracts derived from FLEP cultures. 
Thus, this experiment did not provide convincing results. To obtain more protein extract from 
differentiated erythroblasts, I established the ESEP in vitro culture system. 
 
3.2. Establishment of p38α-deficient ESEP culture 
The ESEP in vitro culture was shown to provide virtually unlimited amount of erythroid cells 
[91]. To exclude false positive results from biochemical experiments, such as p-p38α co-
immunoprecipitation, it is crucial to generate a pure p38α-deficient ESEP culture as a negative 
control. The differentiation of p38α+/+ and p38αf/f ES cells to ESEPs was successful. The 
obtained p38α+/+ and p38αf/f ESEP cultures showed properties similar to independently 
generated wild-type ESEPs, such as proliferation rate and spontaneous differentiation. However, 
it was not possible to generate p38α-deficient ESEPs.  
The first approach was to obtain p38α-deficient ESEPs from p38α-/- ES cells. Interestingly, EBs 
derived from p38α-/- ES cells showed aberrant morphology. Whereas cultures from dissociated 
p38α+/+ EBs showed adherent cell morphologically resembling neurons, myocytes and 
fibroblasts, there were no adherent cells in cultures from dissociated p38α-/- EBs.  Cultures from 
dissociated p38α-/- EBs mainly showed cell clumps in suspension and it was not possible to 
obtain p38α-/- ESEPs from these cells. FACS analysis showed an increased population of 
immature erythroid cells in p38α-/- EBs, indicating differentiation defects in the erythroid 
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lineage. These data imply an essential role of p38α in ES cell differentiation into the erythroid 
lineage in vitro. To further characterize the role of p38α in ES cells differentiation in vitro, it 
would be necessary to analyze independent p38α-deficient ES cells to exclude cell line specific 
effects. 
To circumvent differentiation defects which might be caused by loss of p38α, I generated p38αf/f 
ES cells. p38αf/f ES cells efficiently differentiated into ESEPs. However, it was not possible to 
delete the p38α floxed alleles in ESEPs. The first approach was to establish an 
p38αf/f/CreER(T2) ES cell line, for inducible deletion of the p38α floxed alleles in ESEPs. 
CreER(T2) efficiently integrated into the genome of p38αf/f ES cells, but there was no deletion of 
the p38α floxed alleles detected after inducing recombinase activity by Tamoxifen treatment. 
These data unfortunately imply that CreER(T2) did not exert recombinase activity, likely due to 
insufficient expression levels or gene mutations. 
The second approach was to delete the p38α floxed alleles in ESEPs by lentiviral-mediated 
expression of iCre. The infection of ESEPs and deletion of the p38α floxed alleles was 
successful. However, p38αf/f ESEP cultures expressing iCre died within a few days after 
infection. It was shown before that high expression level of Cre recombinase has genotoxic 
effects in proliferating mammalian cells, suggesting that lentiviral-mediated expression of  iCre 
has toxic effects on ESEPs [95]. 
All my attempts to generate p38α-deficient ESEPs failed and therefore, it was not possible to 
obtain sufficient amounts of protein extracts of differentiated erythroblasts for further analyses of 
p38α binding partners and substrates by co-immunoprecipitation. 
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3.3. Identification of p38α substrates by in vitro kinase assay  
In vitro kinase assay is a commonly used tool to screen for kinase substrates. To identify p38α 
substrates in erythroblasts a p-p38α in vitro kinase assay with protein extracts from differentiated 
erythroblasts was initiated previously in the Wagner lab by Lijian Hui in collaboration with 
Eleanor Coffey, Centre for Biotechnology, Turku. Potential substrates of p38α identified by mass 
spectroscopy analysis were assigned by Eleanor Coffey. However, raw data from mass 
spectroscopy analysis showed a high number of proteins identified per analyzed spots. 
Occasionally there were discrepancy between the migration distance of identified proteins and 
their molecular weight. Moreover, there was no proper control to exclude false positive results. 
These conditions suggest a low specificity of the performed p-p38α in vitro kinase assay. It 
would have been possible to increase the specificity of this assay and exclude false positive 
results by use of protein extracts from p38α-deficient erythroblasts incubated with kinase dead 
p38α protein as negative control. Nevertheless, the identified protein NUDC was shown to be 
activated upon phosphorylation and to be involved in nuclear migration during cytokinesis [96, 
97]. Hence NUDC was an attractive candidate for further characterization. 
 
3.4. The role of NUDC in erythroblast enucleation 
It was shown previously that the activity of NUDC is controlled by phosphorylation and that 
NUDC has an essential role in cytokinesis. Knock-down as well as overexpression of NUDC in 
mammalian cell lines, resulted in multinucleated cells and blocked cytokinesis in midbody stage 
[96, 97]. Noticeable, enucleation of erythroblasts is supposed to resemble asymmetric 
cytokinesis [39-41]. It was shown that genes involved in cytokinesis, such as Rac1 and mDIA2 
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are essential for erythroblast enucleation [42]. As NUDC is activated by phosphorylation I 
hypothesized, that loss of p38α leads to impaired activation of NUDC, which subsequently 
blocks enucleation of erythroblasts. To test this hypothesis I applied shRNA-mediated knock-
down of NUDC to wild-type FLEPs. Interestingly, knock-down of NUDC did not affect the 
enucleation of erythroblasts. Moreover, there were no obvious differentiation defects observed in 
NUDC-deficient erythroblasts. These data imply that NUDC is not involved in differentiation 
and enucleation of erythroblasts, although these data do not exclude that NUDC is a potential 
substrate of p38α. 
 
3.5. Cell-autonomous function of p38α in erythroblast enucleation 
Erythroblast differentiation is facilitated by stromal cells and macrophages in vivo [32, 113]. 
Perturbed function of these cells results in impaired erythropoiesis as well. For instance, 
macrophages of the erythroblastic islands from DNase II-/- mice show defective degradation of 
phagocytosed erythroblast nuclei. Subsequently, this defect results in impaired enucleation of 
erythroblasts [98]. Hence it is crucial to verify whether p38α functions in enucleation of 
erythroblasts cell-autonomously or not. Previous findings showed that the impaired enucleation 
phenotype of p38α∆/∆ during fetal development is recapitulated in newborn p38α∆blood mice and 
also in adult p38α∆blood mice upon anemia-induced stress erythropoiesis [Wagner lab, 
unpublished]. These findings showed that the function of p38α to promote enucleation of 
erythroblasts is dispensable in stromal cells. Preliminary data from the Wagner lab also showed 
that p38α∆mΦ mice have normal enucleation of erythroblasts during stress erythropoiesis. 
Moreover, enucleation of p38α∆/∆ FLEPs was partially rescued in co-culture with wild-type or 
p38α-deficient macrophages. Thus, macrophages lacking p38α appeared capable to facilitate 
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enucleation of erythroblasts as well [Wagner lab, unpublished]. These data implicated that the 
function of p38α to promote enucleation of erythroblasts is cell autonomous. To prove this 
assumption I analyzed erythroblast enucleation in mice specifically lacking p38α in the erythroid 
lineage (p38α∆ery) compared to mice specifically lacking p38α  in macrophages (p38α∆mΦ). 
Noteworthy, defective enucleation of erythroblasts during fetal development and upon anemia-
induced stress erythropoiesis in adult mice was only observed in p38α∆ery and not in p38α∆mΦ 
mice. Thus, the recapitulation of the phenotype in p38α∆ery, but not in p38α∆mΦ mice clearly 
shows that the function of p38α in enucleation of erythroblasts is cell-autonomous.  
 
3.6. In vitro culture to study the role of p38α in erythroblasts  
Previous studies that describe the function of p38α in erythroid differentiation in vitro used 
rather artificial and unspecific methods, such as induced erythroleukemia models or chemical 
inhibition of p38α [86, 112]. Using an in vitro culture system it was shown that p38α-deficient 
erythroblasts undergo differentiation comparable to wild-type erythroblasts, but almost 
completely failed to enucleate during terminal differentiation. In contrast, mice with p38α-
deficient erythroblasts do not show completely blocked erythroblast enucleation under stress 
conditions. The intensified enucleation defect in vitro might be explained by enhanced stress 
conditions as well as the lack of macrophages, which facilitate enucleation of erythroblasts. I 
have shown that the knock-down of p38α resulted in dramatically increased numbers of 
nucleated erythrocytes. Moreover, chemical inhibition of p38α kinase activity in wild-type 
ESEPs showed similar effects. These results further confirm the role of p38α in enucleation of 
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erythroblasts. Recapitulation of the phenotype in p38α-deficient FLEPS and ESEPs allows 
further characterization of the role of p38α using these in vitro culture systems.  
 
3.7. p38α promotes erythroblast differentiation 
The analysis of p38α∆/∆ FLEPs revealed differentiation defects in addition to blocked 
enucleation. It was previously shown that p38α-deficient erythroblasts display surface marker 
expression related to immature erythroid cells in vivo and in vitro [Wagner lab, unpublished]. 
Additionally, it was shown that erythroblasts have aberrant levels of transcription factors 
essential for erythroid differentiation upon treatment with p38α/β-inhibitor in vitro [112]. These 
data suggest that p38α has a function in erythroblast differentiation under stress conditions 
beyond regulating enucleation. Likewise, p38α is essential for up-regulation of muscle-specific 
genes during myogenesis [68]. Here I showed that decreased hemoglobinization is the result of 
reduced expression of several hemoglobin isoforms. Moreover, transcription factors which 
regulate erythropoiesis were aberrantly expressed in p38α∆/∆ FLEPs. In general, Gata1 and 
C/EBPα are up-regulated, whereas Gata2 and Fli-1 are down-regulated during progression of 
erythroblast differentiation [114, 115]. Indeed, this pattern was observed in p38αf/+ FLEPs. 
However, in p38α∆/∆ FLEPs the expression of GATA1 and C/EBPα was reduced and that of 
GATA2 and Fli-1 up-regulated. The attenuated expression of GATA1 and C/EBPα was further 
confirmed by reduced expression of their target genes as shown by GSEA analysis. There was 
aberrant expression of the transcription factor Gfi-1, although the function of Gfi-1 in 
erythroblast differentiation is not yet characterized. Correspondingly, p38α∆/∆ FLEPs exhibited 
an expression pattern related to early hematopoietic progenitors at late stage differentiation, 
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which is most likely the result of the aberrant expression of transcription factors essential for 
erythroblast differentiation. These data show that p38α is essential for regulating gene 
expression during erythroblast differentiation under stress conditions. Consequently, the loss of 
p38α leads to deregulated and diminished maturation. However, it remains to be determined 
whether these defects are also found in vivo. Noteworthy, impaired maturation was also found in 
lung and muscle epithelium lacking p38α [68, 72]. 
 
3.8. p38α is essential for proper activation of the Rb pathway 
Rb has been shown to be an essential regulatory factor in erythropoiesis under stress conditions 
[43]. Rb-deficient erythroblasts have impaired enucleation of erythroblasts during fetal 
development and adult stress erythropoiesis. In vitro Rb-deficient erythroblasts completely fail to 
enucleate, display expression of surface marker genes related to immature erythroid cells and 
have impaired cell cycle exit [43]. It has been shown that the function of Rb in erythroblast 
differentiation is cell-autonomous, although the results are contradictory [43, 116]. These defects 
are very similar to those found in p38α-deficient erythroblasts. Therefore, it is very likely that 
there is a connection between the function of p38α and Rb in erythroblast differentiation under 
stress conditions. Indeed, gene expression profiling and Western blot analysis showed an 
attenuated activation of the Rb pathway in p38α∆/∆ FLEPs. In addition, the delayed cell cycle exit 
found in p38α∆/∆ FLEPs is most likely a direct result of attenuated activation of the Rb pathway. 
Whereas p38α∆/∆ FLEPs have delayed cell cycle exit and finally accumulate in G0/G1 phase, Rb-
deficient erythroblasts were described to have defective cell cycle exit and therefore accumulate 
in G2/M phase [43]. This difference might be explained by partially activated Rb in p38α∆/∆ 
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FLEPs via alternative or compensating pathways. Nevertheless, this result further confirms an 
attenuated activation of the Rb pathway in p38α∆/∆ FLEPs. Recent studies describe several 
pathways by which p38α activity can cause Rb activation [68, 117, 118]. p38α very likely 
regulates the Rb pathway through different molecular pathways in a cell type and context-
specific manner. Here, I was able to show that p38α∆/∆ FLEPs have decreased expression levels 
of major cell cycle regulators, such as p53, p21 and p27. In addition, reduced expression of p21 
and mdm2, both targets of p53, further confirm the attenuated p53 activity. It was shown that 
p53 can be directly phosphorylated and activated by p38α [119]. p53 was found to be essential to 
inhibit proliferation of erythroid progenitors during stress erythropoiesis [120]. Moreover, p21 
and p27 were described to accumulate during erythroblast differentiation [110]. Whereas p27 is 
supposed to play a major role in cell cycle regulation during terminal erythroid differentiation, 
the role of p21 is not yet fully characterized. These data suggest that p38α activates Rb during 
terminal erythroid differentiation most likely through activation of p53 and up-regulation of p21 
and p27. It remains to be determined by which mechanisms p38α up-regulates these cell cycle 
regulators and whether one of these plays a major role.  
 
In conclusion, these data show that activation of the Rb pathway during terminal erythroid 
differentiation under stress conditions is dependent on p38α. As the phenotype of Rb-deficient 
erythroblasts is similar to that of p38α-deficient erythroblasts, I hypothesize that under stress 
conditions the major function of p38α for regulating erythroblast differentiation and enucleation 
is to activate the Rb pathway. Intriguingly, similarities in differentiation defects were also 
described in other progenitor cells lacking either p38α or Rb, such as myoblasts [68, 121]. To 
prove this hypothesis it is necessary to rescue the differentiation defects, most importantly the 
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blocked enucleation of p38α-deficient erythroblasts by endogenous or exogenous activation of 
the Rb pathway. Unfortunately until today my experimental approaches to activate the Rb 
pathway failed due to technical limitations of the methods used.  
 
 
 
4. Material & Methods 
4.1. Mice 
Mice with p38α floxed alleles (p38αf/f) have been described previously [65, 122]. To obtain 
p38α∆/∆  mice, heterozygote MORE-cre / p38αf/+ mice were crossed to p38αf/f mice as described 
by Hui et al [65]. Lysm-cre mice have been described previously [123]. ErGFPcre mice were a 
kind gift from U. Klingmüller, Max-Planck-Institute Freiburg  and have been described 
previously [124]. The LysM-cre / p38αf/f (p38α∆MΦ) and ErGFPcre / p38αf/f (p38α∆ery) mice 
were generated by crossing p38αf/f mice to LysM-cre and ErGFPcre mice, respectively. The 
genetic background of the intercross was C57Bl6/J x 129sv. All animal experiments were 
performed according to permissions from Austrian authorities.  
 
4.2. Phenylhydrazine-induced hemolytic anemia 
Phenylhydrazine (PHZ) (#P26252) was purchased from Sigma-Aldrich. 6 weeks old mice were 
injected intraperitoneally with 60 mg/kg PHZ at day 0 and day 1 as described [125]. Control 
mice were injected intraperitoneally with phosphate-buffered saline (PBS). On day 6 blood 
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samples were collected in EDTA-treated tubes form the tail vain. Blood smears were prepared 
using standard protocol. Mice were sacrificed by cervical dislocation and spleen and bone 
marrow were isolated. To obtain single cell suspension, spleens were squeezed through cell 
strainer and bone marrow cells were squeezed six times through a 27 gauge needle. Splenocytes 
and bone marrow cells were cytospined.  
 
4.3. Cell culture 
p38α+/+ and p38α-/- mouse embryonic stem (ES) cells were a kind gift of B. Binétruy, University 
of Marseille [126]. For generation of p38αf/f ES cells, p38αf/f mice were intercrossed. Blastocytes 
were collected at E3.5 and cultures established as described previously [127]. To obtain feeder 
independent ES cell culture, ES cells were cultured on gelatin coated plates without mouse 
embryonic fibroblast at the beginning of passage 4. Differentiation of the ES cells to ESEPs was 
performed as described by Carotta et al. [91]. To induce EB differentiation, 15 000 ES cells/ml 
were plated on non-coated Petri dishes (Greiner Bio-One, Kremsmünster, Austria) containing EB 
differentiation medium. EB differentiation medium was prepared as followed: IMDM, 2 mM L-
glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin (all from Gibco/BRL), 15% FCS 
(Euroclone), 50% methylcellulose, 50 µg/mL ascorbic acid, 300 µg/mL iron-saturated human 
transferrin (all from Sigma), 5% protein-free hybridoma medium (PFHM-II; Gibco/BRL) and 4 x 
10–4 M MTG. At day 5 of differentiation, EBs were harvested by centrifugation and replated into 
fresh EB differentiation medium and further cultivated for 1 day. At day 6, EBs were harvested 
by centrifugation and were incubated in 1 x Trypsin (Gibco/BRL) at 37° C for 2 minutes. FCS 
was added and EB dissociated by repeated pipetting.  
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FLEPs were obtain from fetal livers isolated at E12.5 to 13.5 as reviewed by Dolznig et al [37]. 
Methods for expansion and differentiation of FLEPs and ESEPs were reviewed by Dolzing et al 
[37]. In brief, FLEPs and ESEPs expansive cultures were daily adjusted to a concentration of 2 x 
106 cells / ml in serum-free medium (StemPro34 plus nutrient supplement; Gibco/BRL) plus 
human recombinant erythropoietin (Epo; 2 U/ml; Erypo; Janssen-Cilag AG, Baar, Switzerland), 
murine recombinant Kit-ligand (KL or stem cell factor [SCF]; 100 ng/ml; R&D Systems, 
Minneapolis, MN), 10–6 M dexamethasone (Sigma), and 40 ng/ml insulin-like growth factor 1 
(IGF-1; Promega, Madison, WI). For differentiation of FLEPs and ESEPs, dead and spontaneous 
differentiated cells were removed by Ficoll (lymphocyte separation medium, 1078 g/cm3, 
Eurobio, France) purification and washed twice with phosphate-buffered saline (PBS). Purified 
erythroblasts were cultivated at 2 x 106 cells/ml in serum-free medium (StemPro34 plus nutrient 
supplement) supplemented with 10 U/ml Epo, 10 ng/ml insulin (Actrapid HM; Novo Nordisk), 3 
x 10–6 M glucocorticoid receptor antagonist ZK112.993, and one mg/ml iron-saturated human 
transferrin. Cell number and size was determined using an electronic cell counter (CASY-1; 
Schärfe-System, Reutlingen, Germany). [37]. 
4.4. Benzidine staining 
Blood smears and cytospins were benzidine stained as described [37]. Cells aliquots were spun 
onto glass lides using a cytospin centrifuge at 150g for 7 min. Cytospins were dried with 
hairdryer. Cyspins were incubated for 4 min in methanol, 2 min in 1% benzidine solution, 1.5 
min in H2O2 solution, washed with H2O for 0.5 min, stained 4 min with Diff Quick Red, 40 sec 
with Diff Quick Blue, washed thoroughly with H2O and dried with hairdryer [37]. Diff Quick 
Red (#130 834) and Diff Quick Blue (#130 835) were purchased from Dade Behring, Austria. 
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4.5. FACS analysis 
Surface marker staining of primary cells was performed as described before [37]. In brief, 
approximately 0.5 x 106 cells were incubated in 500µl of 1% FCS/PBS for 30 min on ice in the 
dark with the respective antibodies directly coupled to fluorochromes at a final concentration of 
1:100. Cells were washed twice in 1% FCS/PBS and analyzed directly. TER119-PE (#553673), 
CD71-APC (#h553266), CD117 (c-Kit)-FITC (#553354) and Mac1-FITC (#553310) monoclonal 
antibodies were purchased from BD Biosciences. Bromodeoxyuridine (BrdU) and propidium 
iodide (PI) double staining was performed as followed. 100 µM BrdU was added to 
differentiation culture 3h before designated points of time. 2 x 106 cells were wash twice in 1% 
BSA/PBS and resuspended in 0,9% NaCL. For fixation cells were added in drops to 5 ml 70% 
Ethanol (ice cold) while vortexing and incubated on ice for 45 minutes. Afterwards, cells were 
pelleted, add to 1ml 2N HCl/0,5% Triton X-100 and incubated for 30 min at room temperature 
(RT) for permealization. Cells were pelleted, resuspend in 1ml 0,1M Sodium Tetraborate, 
pelleted and resuspend in 50µl 0,5% Tween/1%BSA/PBS again. For Brdu-labeling, 20µl α-
BrdU were added and cells were incubated for 20 min in the dark at RT. Finally, cells were 
pelleted, resuspended in 1ml PI- Buffer (50µg/ml PI, 10mM Tris pH 7.5, 5mM MgCl2 and 
200µg/ml RNase A) and analyzed directly. Cells were pelleted by 10 min centrifugation at 1500 
rpm at 4°C.  
 
4.6. Immunoprecipitation of p-p38α 
Phospho-p38 MAPK (Thr180/Tyr182) antibodies (#9211) from Cell Signaling were chemical 
cross linked to Affi-Prep Protein A Support (#156-0006) beads from BioRad. Cross linking and 
immunoprecipitation of p-p38α were performed as described previously [128, 129]. 
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4.7. Vectors, lentiviral particle production and infection of ES cells 
and ESEPs 
pRRLSIN.cPPT.PGK-GFP.WPRE lentiviral vector (Plasmid #12252) was obtained from 
Addgene. IRES-GFP was used from pIRES2-AcGFP1 (#632435) from Clonetech. Plasmids 
containing CreER(T2), iCre and pl4.blockit lentiviral vector were a kind gift from A. Souabni 
and M. Richter / IMP Vienna, respectively. Lentiviral vectors were cloned according to the maps 
shown before (Fig. 13A; Fig. 14B). 
Lentiviral vectors for NUDC knock-down (#NM_010948), p38α knock-down (#NM_011951) 
and plko.1-control vectors (#SHC001) were purchased from Sigma-Aldrich. All vectors were 
purified with the Jetstar Kit purchased from Genomed following manufactures instructions. 
Lentiviral particles were produced as described before using Lipofectamine and Plus Regent for 
transfection following manufactures instructions [130]. Lipofetamine and Plus Reagent (#15338-
100) were purchased from Invitrogen. For infection, at day 0 ESEPs were pelleted and 
resuspendend in viral supernatant containing 8µg / ml polybrene at a concentration of 4 x 106 
cells / ml. To enhance infection rate, ESEPs with viral supernatant were spun for 30 min at 1200 
rpm in round bottom tubes. ESEPs were resuspended and adjusted to 2 x 106 cells / ml with 
erythroblasts proliferation medium. At day1 ESEPs were adjusted to 4 x 106 cells / ml using 
same volume of viral supernatant as used at day 0 and then diluted to 2 x 106 cells / ml with 
erythroblasts proliferation medium. From day 2 to day 3 ESEPs were selected for positive 
infection by addition of 1µg / ml puromycin to the erythroblasts proliferation medium. ES cells 
for infected by lentivirus by addition of 30% viral supernatant of original volume and 4µg/ml 
polybrene to normal ES cell medium. ES cells were selected for positive infection by addition of 
1µg/ml puromycin to ES cell medium for 3 days.  
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4.8. Protein blot analysis 
Protein blot analyses were performed using standard protocols (Amersham Biosciences). We 
used antibodies against the following proteins: p38α (#9212), p-p38α (#9211), p53 (#2524) (Cell 
Signaling), p21 (#556431), Rb (#554136) (BD Bioscience), p27 (#sc-528) and NUDC (#sc-
100794) (Santa Cruz). 
 
4.9. Gene-Chip hybridizations and statistical analysis of data 
The mouse microarray contained a set of 17,000 verified mouse cDNA clones printed onto 
polylysine-coated slides. Approximately 5 mg of total RNA from p38αf/+ and p38α∆/∆ FLEP 
cultures at 0, 24, 36 hours of differentiation was primed in water with 1µl oligo Target Amp T7-
oligo(dT) primer at 65°C for 5 min. Reverse transcription was performed in a mixture containing 
first-strand reaction buffer provided with SuperScriptII (Invitrogen) for 30 minutes at 50°C. 
Second strand DNA Synthesis was carried out using Taq Polymerase (Fermentas) at 65°C for 10 
minutes. Amplification of RNA and Amino Allyl incorporation was performed using Amino 
Allyl MessageAmp aRNA Amplification kit (Ambion). cDNA was generated by incubation for 2 
hours with SuperscriptII at 42°C. Remaining RNA was digested using RNase H. cDNA was 
purified (Qiaquick-kit) dried in speedvac and probes were labeled with a reactive fluorescent dye 
from Molecular Probes (Alexa 555 and 647). The Cy3-dUTP and Labelled probes were pooled 
and precipitated with blocking solution containing mouse Cot1 DNA at 80°C for 20 min. The 
probe was then denatured at 94°C for 1 min followed by prehybridization at 50°C for 1 h. It was 
then added to the microarray slides and incubated at 50°C overnight. After the hybridization, the 
slides were scanned with a Gene Pix 4060 scanner. Analysis was performed using Gene Pix Pro 
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4.1. Raw expression data were normalized to p38αf/+ at 0 hour of differentiation. Fold changes 
and P values were calculated (ANOVA, P<0.05).  The hybridization and part of the analyses was 
performed by A. Mairhofer as part of the IMP-IMBA micro-array service facility. These data 
were sorted for P-value < 0.05 and technical repeats were averaged. Processed data were 
analyzed by “Gene set enrichment analysis” (GSEA) software [100, 101]. 
 
4.10. Quantitative real-time PCR. 
Total RNA was isolated from FLEPs using TRIZOL (Invitrogen) following manufactors 
instructions. cDNA synthesis was performed with the Ready-To-Go You-Prime-It First-Strand 
Beads (Amersham Biosciences). qRT-PCR reactions were performed using SYBR Green 
(Molecular Probes) on an Opticon2 Monitor Fluorescence Thermocycler (MJ Research). 
Following primers were used: p21 (for: ACCCGGGTCCTTCTTGTGTTTC, rev: 
CGTTTTCGGCCCTGAGATGTTC), p27 (for:  GGTGGACCAAATGCCTGACT, rev: 
GCCCTTTTGTTTTGCGAAGA), p53 (for: AACCGCCGACCTATCCTTACCATC, rev: 
AGGCCCCACTTTCTTGACCATTGT), mdm2 (for: CAGAGACGCCCTCGCATC, rev: 
CTGAATCCTGATCCAGGCAATC), Hbb-b1 (for: GACCCAGCGGTACTTTGATAGC, rev: 
TGAGGCTGTCCAAGTGATTCA), Hbb-b2 (for: CCTGGGCAGGTTGGTATCC, rev: 
GGTTTTTCAGGCCCTCGTTAAAG), Hbb-bh1 (for: GAAACCCCCGGATTAGAGCC, rev: 
GAGCAAAGGTCTCCTTGAGGT), Hbb-y (for TGGCCTGTGGAGTAAGGTCAA: , rev: 
GAAGCAGAGGACAAGTTCCCA), Hba-a1 (for: CACCACCAAGACCTACTTTCc , rev: 
CAGTGGCTCAGGAGCTTGA), Hba-X (for: CTACCCCCAGACGAAGACCTA, rev: 
CTTAACCGCATCCCCTACGG),  Gata1 (for: GAAGCGAATGATTGTCAGCA, rev: 
TTCCTCGTCTGGATTCCATC), Gata2 (for: TGCATGCAAGAGAAGTCACC, rev: 
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AGACTGGAGGAAGGGTGGAT), CEBP/α (for: GCTGGAGTTGACCAGTGACA, rev: 
AAACCATCCTCTGGGTCTCC), Gfi-1 (for: AGGAACGCAGCTTTGACTGT, rev: 
CCTGTGTGGATGAAGGTGTG), Fli-1 (for: CAACCAGCCAGTGAGAGTCA, rev: 
GCCCACCAGCTTGTTACATT) and Tubulin (for: CCTGCTGGGAGCTCTACT, rev: 
GGGTTCCAGGTCTACGAA). 
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